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ABSTRACT 
 
Study of Cell Material Interactions for  
Vascular Tissue Engineering Application. (May  2011) 
Xin Qu, B.S., University of Science and Technology of China 
Chair of Advisory Committee: Dr. Mariah Hahn 
 
In the US alone, more than 500,000 coronary artery bypass procedures are 
performed annually. Tissue engineering shows the potential to construct functional grafts 
to overcome the limited availability of autologous saphenous veins, relatively poor 
elasticity and low compliance of synthetic materials (mainly Dacron and 
polytetrafluoroethylene). 
In order to meet the low modulus associate with myocyte differentiation, the high 
suture retention and an ultimate tensile strength (UTS) sufficient to withstand 
implantation and peak physiological stresses, we designed and characterized a multi-
component scaffold comprised of polyurethane electrospun mesh layers bonded together 
by a fibrin hydrogel matrix. We have demonstrated this composite construct retains the 
high tensile strength and suture retention strength but displays a “J-shaped” mechanical 
response similar to that of native coronary artery. 
To improve our design, poly(ethylene glycol) diacrylate based hydrogel system 
was utilized as a blank slate to study the phenotypic regulation by cell material 
interactions. Fibrinogen, fibronectin, laminin and collagen type IV were incorporated 
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into the hydrogel to mimic the stimuli from extracellular matrix (ECM) proteins. 
Surprisingly, no significant effect was detected on induction of smooth muscle cell 
(SMC) differentiation marker expression, activation of mitogen-activated protein (MAP) 
kinases pathway, or alteration of surface integrin expression profile. However, 
fibronectin showed repression of undesired phenotypes in SMC differentiation. 
In contrast to ECM proteins, glycosaminoglycans (GAGs) showed more 
influence on regulating SMC phenotype. By using a scaffold environment intended to be 
mimetic of early atherosclerosis, the impact of GAG identity on SMC foam cell 
formation was explored. We focused on chondroitin sulfate C (CSC), dermatan sulfate 
(DS), and an intermediate molecular weight hyaluronan (HAIMW, ~400 kDa), the levels 
and/or distribution of which are significantly altered in atherosclerosis. CSC and DS 
hydrogels were associated with greater SMC phagocytosis of apolipoprotein B than 
HAIMW gels. However, only SMCs in DS constructs maintained increased expression of 
adipocyte marker A-FABP relative to HAIMW gels over 35 days of culture. 
Combined, our results suggested interesting roles for fibronectin and HAIMW in 
repression of undesired phenotypes in SMC differentiation, which could give insights 
into rational design of novel biomaterials for vascular tissue engineering applications. 
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CHAPTER I 
INTRODUCTION  
 
Blood vessels form a branched system of arteries and veins to circulate blood 
from heart to the tissues and organs. Depending on the location and function, blood 
vessels vary in size, mechanical properties, biochemical content etc. The aorta is the 
largest artery that transports blood originating from the heart. The smaller muscular 
arteries are necessary to deliver blood to the tissues and organs, and with the smaller 
arterioles and the smallest capillaries, blood can be distributed within tissue and organs 
(1). 
In the US alone, the disease of small and medium-sized blood vessels is one of 
the primary causes of the death (2). Blood vessel replacements are often necessary in the 
treatment of advanced atherosclerosis, aneurysmal and peripheral vascular disease, etc. 
For example, in the US alone, more than 500,000 coronary artery bypass procedures are 
performed annually (3). Although autologous saphenous veins and mammary arteries are 
the preferred graft materials for these small-caliber vessels (< 6 mm ID), roughly 10 to 
20% of patients lack usable tissue (4). Moreover, due to the thrombogenicity, relatively 
poor elasticity, and low compliance, synthetic materials, such as polyethylene 
terephthalate (PET) and polytetrafluoroethylene (PTFE) fail as small-caliber vessel 
replacements, although they show good outcome as peripheral vessel grafts (5). 
Therefore, an urgent clinical need emerges to find an alternative supply of vessels to 
_______ 
This dissertation follows the style of Tissue Engineering. 
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replace diseased arteries. Tissue engineered vascular grafts (TEVGs) represent potential 
source of alternate prostheses for situations where autologous tissue is unavailable and 
synthetic prostheses fail (6). 
Tissue engineering has already had success in fabricating materials for treatment 
of chronic wounds and burns, and showed promising results in repair of cartilage defects. 
But in order to generate appropriate blood vessel replacement by tissue engineering 
approaches, some substantial challenges need to be faced. First, the construct will have 
sufficient ultimate tensile strength (UTS) not to burst with changes in blood pressure. 
Second, the grafts should have elastic wall to withstand cyclic loading, matching 
compliance with the adjacent host vessel. Third, the grafts should support smooth 
muscle phenotype and avoid induction of disease phenotypes (1). 
 
1.1 Native Coronary Artery Anatomy 
A better understanding of the normal anatomy of the artery, (shown in Figure 1), 
provides the insight for the design of tissue engineered vascular grafts for coronary 
artery bypass. 
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Figure 1. Anatomy of artery wall. (Adapted from Lafleur et al (7)) 
 
The artery wall consists of three layers: adventita, media and intima. The 
outermost adventitia is rich in longitudinal collagen fiber and sometimes fibroblast can 
be found. The tunica media layer is in the middle of the artery wall and displays mature 
smooth muscle cells (SMCs) embedded in elastin rich matrix. The media layer is thicker 
in artery than in the vein and provides elastic response and vasoactivity associated with 
arterial tissue. The intima is the innermost layer mainly formed by one layer of 
endothelial cells and performs direct contact with blood. 
 
1.2 Tissue Engineering 
Tissue Engineering is an interdisciplinary field that applies the principle of 
engineering and the life sciences toward the development of biological substitutes that 
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restore, maintain, or improve tissue function (8). The basic principle of present Tissue 
Engineering is the combination of appropriate cells with engineered biomaterials under 
designate conditions that facilitate and lead to tissue formation. In general, three 
strategies have been used to treat diseased or injured tissues: 1) cellular implantation; 2) 
tissue implantation; and 3) in situ tissue regeneration. For cellular implantation, freshly 
isolated or cultured cells from the patient or a donor are injected into the defect tissue. 
Alternatively, some degradable scaffold can be combined with the cells in vitro before 
the implantation too. For the tissue implantation, patient or donor cells can be cultured 
on a scaffold to create a 3D tissue in vitro and then implanted the mature construct to the 
target tissue. For in situ regeneration, the scaffold alone can be injected directly into the 
defect to promote local tissue repair with the body’s own cells (9). In addition to the 
therapeutic application, tissue engineering can also create model systems in vitro for 
diagnostic applications such as drug metabolism, toxicity. 
Biomaterials have been one crucial mainstay of tissue engineering due to the 
engineering for scaffolds. A tissue engineering scaffold is a material that supports the 
cells for their growth, proliferation, and differentiation in the absence of native 
extracellular matrix (ECM). Biomaterial can be fabricated from either natural materials 
(collagen, alginate) or synthetic polymers (poly ethylene glycol, polylactide). The ideal 
biomaterial as a scaffold would incorporate specific biochemical cues that could interact 
with target cells required for repair of damaged tissue. The scaffold could stimulate cell 
growth after guiding the migration of the target cells into the defect (9).  
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1.3 Research Plan 
My research focuses on study the cell material interactions in smooth muscle 
differentiation and regulation of smooth muscle phenotype, and applying tissue 
engineering principles to improve the design of tissue engineering scaffolds for vascular 
tissue engineering application. The overall approach to this work is outlined below in 
Figure 2. 
 
 
Figure 2. Scope of research. 
 
In order to fabricate the scaffolds suitable for tissue engineered vascular graft, 
especially coronary artery bypass grafts, the materials should at least meet: 1) 
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appropriate mechanical response mimicking native vascular tissue; 2) sufficient suture 
retention strength and an ultimate tensile strength (UTS) to withstand implantation and 
peak physiological stresses. In the present work, we have demonstrated that a multi-
component scaffold comprised of polyurethane electrospun mesh layers (intended to be 
mimetic of arterial collagen fiber loading) bonded together by a fibrin hydrogel matrix 
(intended to be mimetic of arterial elastic fiber response) results in a composite construct 
which retains the high tensile strength and suture retention strength of electrospun mesh 
but which displays a “J-shaped” mechanical response similar to that of native coronary 
artery. We also studied the cell-material interactions inside the scaffolds in terms of 
ECM production and cell infiltration. 
In designing tissue engineering vascular grafts, a great challenge is to obtain a 
well organized and functional media layer which is mainly comprised of mature SMCs. 
The better understanding of cell-material interactions would be really meaningful to 
further improve our design of tissue engineered vascular grafts. To study the cell 
material interactions, we first focused on impact of ECM protein identity on SMC 
differentiation. Poly (ethylene glycol) diacralyte (PEGDA) gel was used to incorporate 
ECM proteins, such as fibrinogen, fibronectin, etc, into the scaffold. The differentiation 
markers and surface integrins as well as cell signaling switches were monitored to assess 
the cellular behaviors. 
Glycosaminoglycans (GAGs) are also critical components in the ECM. It is 
recognized that GAG retention of lipoproteins is a key event in SMC foam cell 
formation (10), which is an important phenomena in early atherosclerosis. To explore 
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the impact of GAG identity on SMC phenotype a scaffold environment was used to be 
mimetic of early atherosclerosis. Specifically, the effects of chondroitin sulfate C (CSC), 
dermatan sulfate (DS), and an intermediate molecular weight hyaluronan (HAIMW, ~400 
kDa) were examined, as the levels and/or distribution of each of these GAG types are 
altered in early atherosclerosis. 
 
1.4 Contributions 
 To the best of our knowledge, the spiral structure of the mesh-hydrogel 
composites is the first time to be used in tissue engineered grafts, and showed “J-shaped” 
mechanical response similar to that of native coronary artery in contrast to the 
conventional bi-layered design that usually displays linear mechanical response. In 
addition, our study is the first report to utilize three dimensional PEGDA hydrogel 
system to study impact of ECM components on smooth muscle cell differentiation 
uncoupling other scaffold properties, such as mesh size, modulus. As discussed below in 
detail, ECM proteins showed limited impact on smooth muscle differentiation, which 
was contradicting to several previous studies in two dimensional cell culture system. The 
discrepancy may suggest the importance of using 3D cell culture system to better probe 
the natural cell behaviors. Moreover, we have also showed fibronectin and intermediate 
molecular weight hyaluronan can facilitate the suppression of certain undesired disease 
phenotypes of smooth muscle cells. These findings could provide important clues to 
rational design of new biomaterials for vascular tissue engineering applications.  
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CHAPTER II 
HYDROGEL-ELECTROSPUN MESH COMPOSITES FOR CORONARY ARTERY 
BYPASS GRAFTS* 
 
2.1 Introduction 
Each year approximately 500,000 coronary artery bypass procedures are 
performed in the US alone(3). Although autologous saphenous veins and mammary 
arteries are the preferred graft materials for these small-caliber vessels (< 6 mm ID), 
roughly 10 to 20% of patients lack usable tissue(4). Prostheses formed from synthetic 
materials, such as polyethylene terephthalate (PET) and polytetrafluoroethylene (PTFE), 
are suitable as peripheral vessel grafts, but fail as small-caliber vessel replacements due 
to their thrombogenicity, relatively poor elasticity, and low compliance(5). Tissue 
engineered coronary artery bypass grafts (CABGs) represent a potential source of 
alternate prostheses for situations where autologous tissue is unavailable and synthetic 
prostheses fail. 
A successful tissue engineered arterial graft must support smooth muscle 
phenotype while also displaying a suture retention strength and an ultimate tensile 
strength (UTS) sufficient to withstand implantation and peak physiological stresses. 
CABGs should also exhibit key features of the “J-shaped,” circumferential stress-strain  
_______ 
*Reprinted with permission from “Hydrogel-Electrospun Mesh Composites for 
Coronary Artery Bypass Grafts” by R.E. McMahon, X. Qu, A.C. Jimenez-Vergara, C.A. 
Bashur, S.A. Guelcher, A.S. Goldstein, M.S. Hahn, 2011. Tissue Engineering Part C, 
17(4), 451-461, Copyright [2011] by Mary Ann Liebert, Inc. Publishers. 
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curve characteristic of arteries since the operating stiffness of a vessel modulates its 
internal stress and mass transport, both of which critically impact vessel health (11). In 
addition, mechanical mismatch between graft and host tissue at physiological pressures 
can lead to aneurismal failure (11, 12). In native arteries, this biphasic stress-strain curve 
arises primarily from the interplay between the collagen and elastic fibers of the arterial 
medial layer (13), as demonstrated in a classic study by Roach and Burton (13). 
Specifically, by selectively digesting collagen or elastin from samples of human artery, 
their individual mechanical roles were elucidated. It was found that the initial “low 
stiffness” response of the artery wall is dominated by elastic fibers, while the “high 
stiffness” response observed at increased strains primarily represents the contribution of 
tensed collagen fibers. The “upturning region” between the “low stiffness” and “high 
stiffness” segments of the stress-strain curve corresponds to the normal in vivo range of 
arterial loading and appears to arise from the progressive mechanical recruitment and 
straightening of collagen fibers with increased arterial distension. This “J-shaped” 
arterial mechanical response has been difficult to mimic with single component scaffolds 
(6, 14-16). A multi-component scaffold comprised of interpenetrating layers of a high 
stiffness and strength material (intended to mimic the contribution of collagen fibers to 
vessel mechanical response) and a low stiffness material (designed to mimic the 
mechanical role of elastic fibers) may result in a composite construct that approaches the 
biphasic, circumferential mechanical response of native vessels while retaining 
necessary tensile strength and suture retention strength. 
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In the present work, we investigate the feasibility of this approach through the 
development and characterization of a composite construct comprised of layers of 
poly(ester urethane) urea (PEUUR) electrospun mesh bonded together by layers of 
poly(ethylene glycol) (PEG)-fibrin hydrogel. Electrospun mesh scaffolds were selected 
for the “high stiffness” component of the composite scaffolds for a number of reasons. 
First, electrospinning technology is capable of producing nano- and micron-scale fused 
fiber constructs that display high stiffness and high tensile strength while maintaining 
open porous networks (17). In addition, the ability to control fiber alignment through 
modulation of electrospinning conditions can be used to mimic vessel mechanical 
anisotropy (18). PEUUR elastomers were chosen as the base polymer for the electrospun 
layers instead of collagen or gelatin due to the greater tunability of PEUUR material 
properties (19, 20). Specifically, the elastic modulus, strain to failure, UTS, and 
degradation rate of these elastomers can be broadly tailored through careful control of 
the chemistry and molecular weight (Mw) of the individual PEUUR segments (20-22). 
In the current study, the PEUUR polymer formulation and electrospinning conditions 
were selected based on previous literature (19-24) to yield an oriented mesh scaffold 
with a directional modulus appropriate to the “high stiffness” region of the coronary 
artery stress-strain curve. 
Similarly, hydrogels were selected for the “low stiffness” component of the 
hybrid constructs due to the relatively low moduli generally displayed by these materials  
(25). PEG-fibrin gels in particular were chosen for examination for several reasons. First, 
the hydrogel component of the proposed composite scaffolds must function to bond 
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together separate electrospun mesh layers in addition to providing a “low stiffness” 
response. Fibrin gels have known adhesive properties, and fibrin “glues” have been 
widely tested for medical applications (26). In addition, fibrin hydrogels have been 
previously shown to hold promise as tissue engineered vascular graft scaffolds (27-
30)and are believed to support the elastogenesis important to the maintenance of long-
term graft mechanical properties (29). In the present work, the fibrin hydrogel 
composition was selected based on previous literature (27-30) to display a low-strain 
elastic modulus appropriate to the initial toe region of the coronary artery stress-strain 
curve. PEG chains were grafted onto the fibrin gel network to modulate its degradation 
rate (31, 32). We demonstrate that the composite scaffolds prepared by bonding together 
layers of the selected PEUUR mesh with the PEG-fibrin hydrogel matrix exhibited a “J-
shaped” stress-strain response similar to that of native human coronary artery. Moreover, 
we show that these hybrid constructs display suture retention strengths and UTS 
appropriate for implantation at the time of preparation while supporting longer-term cell 
infiltration and extracellular matrix accumulation. 
 
2.2 Materials and Methods 
2.2.1 Poly(ethylene glycol) Diacrylate Synthesis 
 Diacrylate-derivatized PEG (PEGDA) was prepared as previously described by 
combining 0.1 mmol/mL dry PEG (3.4 kDa; Sigma), 0.4 mmol/mL acryloyl chloride 
(Sigma), and 0.2 mmol/mL triethylamine (Sigma) in anhydrous dichloromethane (DCM; 
Fisher Scientific) and stirring at 4 °C under argon overnight (33). The resulting solution 
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was washed with 2 M K2CO3 and separated into aqueous and DCM phases to remove 
HCl. The DCM phase was subsequently dried with anhydrous MgSO4, and PEGDA was 
precipitated in diethyl ether (Fisher Scientific), filtered, and dried under vacuum. 
2.2.2 Electrospun Mesh Fabrication  
 PEUUR Synthesis. A linear segmented degradable PEUUR elastomer, 
consisting of an alternating poly(ε-caprolactone) (PCL) soft segment and a urethane- and 
urea-containing hard segment, was synthesized using a standard two-step technique in a 
three-neck, round-bottom flask equipped with argon inlet and outlet, condenser, and 
stirrer (34). First, the flask was charged with anhydrous dimethyl sulfoxide (DMSO; 
Acros Organics) and 1,6-diisocyanatohexane (HDI; Sigma-Aldrich), immersed in a 75 
oC oil bath and purged with argon. Next, PCL diol (average Mw 2000 Da, PCL2000; 
Sigma) that had been dried for 24 h at 80 °C under vacuum and dissolved in DMSO was 
charged into the reactor. The prepolymer content in the reactor was controlled at 14 wt%, 
and the relative masses of HDI and PCL2000 were selected to achieve a prepolymer 
NCO:OH equivalent ratio of 2.0:1.0. Dibutyltin dilaurate (Sigma) was added to the flask 
at 1000 ppm, and the reaction was allowed to proceed for 3 h to produce an 
HDI.PCL2000.HDI prepolymer. In the second step, a solution of 1,3-propanediol bis(4-
aminobenzoate) (Sigma) in DMSO was prepared at 50 °C and added to the reaction 
vessel. The NCO:OH equivalent ratio of the polyurethane was controlled at 1.03:1.0, and 
the polymer concentration was 12 wt%. Dibutyltin dilaurate was added to a 
concentration of 1000 ppm. The reaction was allowed to proceed at 80 oC for 20 h. The 
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final polymer, PEUUR2000, was then precipitated in diethyl ether (Sigma) and dried for 
24 h at 8 °C under vacuum. 
 Electrospinning Procedure. The PEUUR2000 was electrospun to form fused-
fiber meshes with controlled fiber diameter and fiber alignment as described previously  
(34). Briefly, electrospinning was performed with a 10 wt% PEUUR2000 solution in 
50:50 isopropanol:1,1,1,3,3,3-hexaflouro-2-propanol (HFIP; Sigma) using a 22-gauge 
Teflon tipped needle, a 15 kV potential, a throw distance of 15 cm, and a syringe flow 
rate of 3 mL/h. A 6-cm-diameter drum rotating at a linear velocity of 7.9 m/s served as 
the collector, and spinning time was selected to yield mesh sheets of ~80 µm thickness. 
Meshes were removed from the drum and soaked in ethanol for 7 days followed by 
soaking in deionized water for 2 days to remove residual HFIP. The meshes were then 
dried followed by sterilization using a Co-60 γ-irradiator (Model 484R, JL Shepherd and 
Associates).  
2.2.3 Electrospun Mesh Characterization 
Fiber Diameter and Alignment. The mean diameter and angular deviation of 
fibers within the electrospun mesh sheets were determined by quantitative analysis of 
scanning electron microscopy (SEM) images. Briefly, electrospun meshes were mounted 
onto studs and sputter-coated with Pd. Images were acquired using a LEO 1550 Field 
Emission SEM (Carl Zeiss SMT) operating at 5 kV. Resultant images were imported 
into ImagePro Plus software (ICube), and fiber diameter and angle of orientation were 
determined per Bashur et al (34). 
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Mechanical Testing of Electrospun Mesh Rings. To permit direct comparison 
of mesh mechanical properties with those of the tubular hydrogel-mesh composites, 
rectangular 1.5 cm x 3.5 cm mesh strips were cut with the short edge parallel to the 
direction of fiber alignment. These stripes were subsequently wrapped around a 4 mm 
glass rod so as to give circumferentially-oriented fibers. The seam of the wrapped mesh 
was temporarily secured with knotted Dacron thread, and 0.3 µL of 50:50 
isopropanol:HFIP was pipetted at ~ 3 mm intervals along the mesh seam. The solvent 
locally dissolved the mesh fibers but not the Dacron string. The dissolved mesh fibers 
reset as the solvent evaporated to form a cohesive tubular mesh.  
 Five ring segments 3-5 mm in width were cut from the resultant mesh, after 
which the segments were wetted in PBS. Circumferential mechanical tests were 
performed using a modification of the ring testing technique validated in Johnson et al 
(35). In brief, each segment was mounted onto an Instron 3342 using custom brackets 
(36). The ring segments were exposed to uniaxial strain at a rate of 6 mm/min until 
failure. Applied stress was calculated from the measured force by approximating the area 
of force application as two rectangles, each with sides equal to the width and wall 
thickness of the ring. The gauge length was taken as the mid-wall construct diameter, Dv, 
which was defined as inner diameter of the unstretched ring plus the wall thickness, hv. 
The UTS was defined as the maximum stress applied prior to failure. The tangential 
modulus of each ring mesh sample was defined as the slope of the resulting stress–strain 
curve at a reference stress of 330 kPa. This reference stress was selected to represent the 
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circumferential stress, σθ, that would be experienced by vessels of similar dimensions at 
physiological pressures (σθ ~ 0.5PavgDv/hv, Pavg ~ 100 mmHg) (35). 
2.2.4 PEG-Fibrin Hydrogel Fabrication and Characterization 
 Based on the modulus of the “low stiffness” region of the coronary artery stress-
strain curve (12) and based on previous fibrin hydrogel literature (27-30), a 3 wt% fibrin 
gel was selected for examination. To fabricate these hydrogels, sterile-filtered thrombin 
(Sigma) was added to sterile-filtered, human fibrinogen (MP Biomedicals) in PBS to 
achieve a 3 wt% fibrinogen solution containing 5 U/mL thrombin. The resulting solution 
was rapidly pipetted into separate wells of a 12 well plate. Following 30 min incubation 
at room temperature, the gels were immersed in PBS containing 1.3 U/mL thrombin, 0.5 
wt% 3.4 kDa PEGDA, and 0.26% photoinitiator (Irgacure 2959; Ciba). After 1 h at 37 
°C, the hydrogels were removed from the thrombin-PEGDA solution and exposed to 
longwave UV light (~10 mW/cm2; UVP) for 5 min. The extended thrombin exposure 
was intended to increase fibrin crosslinking and therefore to increase the mechanical 
strength of the network. In addition, since PEG-grafting to protein networks has been 
demonstrated to reduce the rate of protein degradation (31), PEGDA and photoinitiator 
were incorporated into the immersion solution to enable PEG conjugation to the fibrin 
gel. To ensure PEG-grafting to the fibrin network rather than the formation of 
interpenetrating fibrin and PEGDA hydrogel networks, the concentration of PEGDA in 
the immersion solution was maintained below the level required to support hydrogel 
formation. The ability of acrylate-terminated PEG to conjugate to the fibrin network was 
confirmed using a fluorescently-labeled monoacrylate-derivatized PEG (data not shown). 
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To mechanically test the PEG-fibrin gels, 6 mm punches were cored from the central 
region of each 22 mm hydrogel disc and mounted onto an Instron 3342. Following 
application of a 0.05 N preload, each hydrogel was subjected to unconfined compression 
at a strain rate of 1 mm/min from 0 to 25% strain. 
2.2.5 Cell Culture 
 Mouse smooth muscle progenitor cells (10T½, American Type Culture 
Collection) at passage 2 were thawed and expanded at 37 °C and 5% CO2. During 
expansion, cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; 
Mediatech) containing 10% heat-inactivated fetal bovine serum (FBS; Hyclone). Cells 
were harvested for seeding and/or encapsulation between passages 10 and 12. 
2.2.6 Hybrid Hydrogel-Mesh Construct Fabrication  
 To fabricate tubular hybrid constructs, molds were employed that consisted of a 
Teflon base, an outer hollow cylinder of Teflon (~5.5 mm ID, 0.30 mm wall thickness; 
Small Parts, Inc.), and an inner, thin-walled latex tube (~3.25 mm OD, 0.38 mm wall 
thickness; Kent Elastomers) supported by a 2 mm glass rod. All mold components were 
sterilized by autoclaving. Each construct was fabricated in a three-step process shown 
schematically in (Figure 3A). In brief, rectangular segments (2 cm × 3.5 cm) were cut 
from the electrospun mesh sheets such that the short edge of the rectangle was parallel to 
the average direction of fiber orientation. Next, each mesh segment was exposed to 
media containing 40% serum overnight at room temperature to improve cell adhesion. 
The coated mesh segments were then rinsed with PBS, and cells were seeded on the  
 17
upper mesh surface at 104 cells/cm2. Following two days of culture, the cell-laden 
meshes were rolled around the latex mandrels (Figure 3A), resulting in ~2 concentric 
mesh layers and a mean circumferential orientation of the mesh fibers. During the rolling 
process, the cell layer faced outward and mesh segments were handled only at the edges 
to limit mechanical removal of seeded cells. Sterile-filtered thrombin and harvested 
10T½ cells were added to sterile-filtered human fibrinogen in PBS to achieve a final 
solution containing 3 wt% fibrinogen, 5 U/mL thrombin, and 5x106 10T½ cells/mL. 
Immediately following the addition of thrombin, the fibrinogen-cell suspension was 
rapidly pipetted around the inner, mesh-wrapped mandrel. The thrombin content of this 
fibrinogen solution had previously been tuned to provide the relatively slow 
polymerization rate needed to allow fibrinogen to impregnate the mesh layers prior to 
polymerization while simultaneously resulting in a hydrogel of sufficient mechanical 
strength to permit removal of an intact hydrogel-mesh composite from the mold. 
Following 30 min incubation at room temperature, the constructs were removed from the 
molds and immersed in PBS containing 1.3 U/mL thrombin, 0.5 wt% 3.4 kDa PEGDA, 
and 0.26% Irgacure 2959. After 1 h at 37 °C, the constructs were removed from the 
thrombin-PEGDA solution, and exposed to longwave UV light (~10 mW/cm2, UVP) for 
5 min. The resulting constructs (~3.5 cm length, ~5.5 mm OD, ~1 mm thickness) were 
then immersed in media containing 10% FBS and 1% PSA (10 U/L penicillin, 10 g/L 
streptomycin, and 25 mg/L amphotericin; Mediatech). In addition, 1 ng/mL transforming 
growth factor 1 (TGF-1; Sigma) was added to the culture media to promote 10T½ 
differentiation into smooth muscle-like cells (37, 38). 
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Figure 3. Hybrid hydrogel-mesh construct fabrication. (A) A schematic demonstrating construct 
fabrication procedure. Briefly, a cell-seeded electrospun mesh is wrapped around a hollow latex mandrel, 
followed by mold assembly and the addition of a fibrinogen-thrombin hydrogel precursor solution which 
impregnates the mesh layers as the fibrinogen polymerizes. The resulting fibrin mesh construct is then 
removed from the mold, after which thrombin exposure is repeated and PEGDA is grafted to the fibrin 
network. (B) An image of a PEG-fibrin mesh composite construct mounted onto the ports of a pulsatile 
bioreactor construct chamber and secured with Dacron thread. Scale bar = 5 mm.  
    
2.2.7 Time-Zero Construct Analyses 
 Following 24 h of additional culture, 3-5 mm ring segments were harvested from 
the hybrid gel-mesh constructs for tangential modulus, UTS, and suture retention 
strength measurements. In addition, separate segments were collected for cell viability 
assessment and SEM imaging.  The inner latex tubing was gently removed prior to 
performance of these tests. 
Mechanical Property Assessment. Circumferential mechanical tests were 
conducted on ~3 mm hybrid scaffold ring segments (n = 4). These tests were performed 
per the methodology described for the tubular mesh ring segments, except that the 
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tangential modulus of each sample was defined as the slope of the stress–strain curve at 
a reference stress of 30 kPa rather than 330 kPa. As previously discussed, the reference 
stress was selected to represent the circumferential stress that would be experienced by 
vessels of similar dimensions at Pavg ~ 100 mmHg (σθ ~ 0.5PavgDv/hv) (35). Thus, this 
shift in reference stress reflects the shift in construct dimensions between the mesh-only 
scaffolds and the hybrid gel-mesh constructs.  
 For assessment of suture retention strength, ~5 mm hybrid construct ring 
segments were glued along their cylindrical base to rectangular pieces of wood using 
cyanoacrylate-based glue. Each wood piece was subsequently clamped to the lower grip 
of an Instron 3342. A loop of 5–0 PDSTM suture (Ethicon) was created ~2 mm from the 
upper edge of each sample and secured to the upper clamp of the testing device. The 
force required to pull-out the suture was monitored at a constant cross-head speed of 150 
mm/min. Suture retention strength was considered to be the maximum force recorded 
prior to suture pull-through and was examined for n = 4 specimens. 
Cell Viability Analysis. To confirm the cytocompatibility of the extended 
thrombin-PEGDA exposure associated with hybrid gel-mesh construct fabrication, 
LIVE-DEAD staining (Invitrogen) was performed per standard protocols for n = 3 
specimens. 
SEM Analysis. To examine the interpenetration of the fibrin gel and electrospun 
mesh components of the composite constructs, ring segments were fixed in 10% acrolein 
(Sigma) and dehydrated with a graded ethanol series (5-100%) with intermittent vacuum 
in a PELCO Biowave microwave system (Ted Pella, Inc.) at 200 W and 10 C.  One 
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min microwave cycles were used for dehydration until 50% ethanol, after which 6 min 
cycles were used to complete the dehydration process. Final dehydration consisted of 
three changes of 100% ethanol with intermittent vacuum and 6 min microwave cycles. 
Ethanol was then replaced with three changes of hexamethyldisilizane (Electron 
Microscopy Sciences) followed by the intermittent vacuum and microwave cycles. The 
resulting ring segments were mounted along their base onto stubs, after which they were 
exposed to ruthenium tetroxide vapor (Sigma), sputtercoated with Au:Pd (60:40), and 
imaged in a JEOL 6400 SEM equipped with a tungsten filament at an accelerating 
voltage of 10 kV. 
2.2.8 Exposure of Hydrogel-Mesh Constructs to Physiological Pulsation 
 Remaining hybrid hydrogel-mesh constructs were cultured statically for 2 days 
following initial fabrication, after which each construct was cut in half using sterile 
surgical scissors (resulting in a series of constructs ~1.5 cm in length). One half of each 
construct was randomly assigned for dynamic culture, while the remaining portion was 
allocated for static culture. Dynamic constructs were mounted in the construct chamber 
of a modified version of the pulsatile flow bioreactor previously described in Bulick et al  
(36). The low-stiffness, thin-walled latex tubing employed as the inner mandrel during 
composite construct fabrication ensured the formation of a tight seal between the graft 
lumen and the construct chamber ports per Syedain et al (39). The end-segments of the 
mounted constructs were then further secured with sterile Dacron thread (Figure 3B), 
and fluid flow through the constructs was increased until luminal pressures of ~85 
mmHg were achieved. Pulsation (P ~ 20 mmHg at 60 beats per min) was initiated 
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using a CellMax pump (Spectrum Labs). The pressure waveforms experienced by the 
constructs were monitored using pressure transducers (Merit Medical) placed 
immediately upstream and downstream of each construct. Each pressure transducer was 
equipped with a valve, which was used to match resistances in the construct lines.  
 During the period of mechanical conditioning, both static and dynamic constructs 
were cultured in DMEM, 10% FBS, 1% PSA, 1 ng/mL TGF-1, with 2 mg/mL ε-
aminocaproic acid to slow fibrin degradation, and 50 µg/ml ascorbic acid to increase 
collagen production.  Media was changed for all constructs every two days for 12 days. 
To estimate the circumferential strain experienced by the constructs during mechanical 
conditioning, the measured tangential moduli (E) and vessel dimensions were input into 
the Bernoulli equation Eh
DP
v
v)(5.0~ 
, with Dv and hv as previously defined (40). 
Although the Bernoulli equation does not account for the structural inhomogeneity of the 
fibrin-mesh constructs, it served as an initial estimate of the strains experienced within 
the construct due to the applied cyclic loads. 
2.2.9 Endpoint Construct Analyses 
 Following 16 days of total culture (16 days = 2 days of culture prior to mesh 
rolling + 2 days post-rolling but prior to static versus dynamic allocation + 12 days post-
onset of mechanical conditioning), each PEG-fibrin-mesh construct was cut into 5 ring 
segments, each ~3 mm in length. The two end-segments were discarded, and the inner 
latex tubing was gently removed from the remaining segments. One segment per 
construct was allocated for mechanical testing. The remaining sections were allocated 
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for histological or biochemical assays. Endpoint scaffold tangential modulus and UTS 
assessments were performed as for the 24 h constructs. Details of the biochemical and 
histological analyses are given in the following sections. 
Biochemical Analyses. Samples for biochemical analyses were transferred to 2 
mL screw-cap microfuge tubes containing 1 mL of 3.2 mm stainless steel beads 
(Biospec) and  1.5 mL of lysis buffer (PBS containing 1% Triton X-100 (Fisher), 0.5% 
sodium dodecyl sulfate (Sigma), and 100 µg/mL phenylmethanesulfonylfluoride 
(Sigma)). Each sample segment was homogenized at 4800 rpm in a Bead-Beater 
homogenizer (Biospec) in 10 sec cycles with 1 min intermediate cooling on ice. The 
homogenate was then clarified by centrifugation, and aliquots of the supernatant were 
stored at -80 °C. At the time of analysis, thawed aliquots were evaluated via competitive 
ELISA for arterial ECM proteins collagen I (COL1A1; clone D-13), collagen III 
(COL3A1; clone S-17), and elastin (clone BA-4). In addition, the housekeeping protein 
GAPDH (clone V-18) and smooth muscle cell (SMC) markers calponin h1 (clone N-15) 
and SM22α (clone P-15) were examined.  
 Competitive ELISAs were conducted per standard procedures. In brief, blocking 
peptides for each antibody, except for the elastin antibody, were obtained from Santa 
Cruz Biotechnology (SCBT). For the elastin antibody, bovine α-elastin (Sigma) was 
used as a source of blocking peptides. EIA plates (Costar) were coated with the 
appropriate peptide at either 500 ng/well (collagen III peptide) or 2000 ng/well (collagen 
I, calponin h1, SM22α, α-elastin, GAPDH peptides). Coated wells were then blocked 
with bovine serum albumin (BSA) and rinsed with PBS. Aliquots of each sample were 
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incubated with primary antibody (SCBT) for 1 h, after which the sample-antibody 
mixtures were applied to coated wells for 1 h. Standard curves were similarly prepared 
by incubating primary antibody with varying levels of blocking peptide for 1 h, followed 
by solution application to coated wells. For both samples and standards, primary 
antibody which had bound to the coated well surface was detected using an appropriate 
HRP-conjugated secondary antibody (Jackson Immunoresearch), followed by 
application of 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (Sigma) and 
monitoring of absorbance at 410 nm. Each target protein was as analyzed in duplicate for 
each sample (n = 8 samples per treatment group). 
Histological Analyses. Histological segments were formalin-fixed, embedded in 
OCT media, and cut into 10 μm transverse sections which were mounted onto charged 
glass slides. Standard immunostaining protocols were employed. In brief, rehydrated 
sections were blocked by 30 min exposure to Terminator (Biocare Medical). Primary 
antibodies for collagen I (Rockland Immunochemicals), collagen III (Rockland 
Immunochemicals), and SM22α (clone P-15; SCBT) were diluted in PBS containing 3 
% BSA and 0.5 % Tween 20 and applied overnight at 4 °C. Bound primary antibody was 
detected using an appropriate HRP-conjugated secondary antibody (Jackson 
Immunoresearch) followed by application of the chromogen 3,3’-diaminobenzidine 
(Biocare Medical). Stained sections were then dehydrated with graded alcohol, 
transferred to xylene, and coverslipped using either Polymount (Polysciences) or 
Curemount (Instrumedics). Stained sections were imaged using an Axiovert microscope 
(Zeiss). Cryosections of static and dynamic samples exposed to species-specific IgG 
 24
control serum in place of primary antibody served as negative controls for each 
immunostaining procedure. 
2.2.10 Statistical Analyses 
 Data are reported as mean ± standard error of the mean. Comparison of sample 
means was performed by one-way ANOVA using SPSS software, p < 0.05. 
 
2.3 Results 
2.3.1 Electrospun Mesh and PEG-Fibrin Hydrogel Characterization 
 PEUUR mesh sheets were prepared using spinning conditions intended to yield 
1-2 µm fiber diameters, relatively high fiber alignment, and ~80 µm thick sheets. SEM 
imaging of the resulting mesh layers revealed a mean fiber diameter of 1.07 ± 0.35 µm, a 
fiber angular deviation of ~21° (indicative of highly aligned fibers), and a mesh 
thickness range of ~60-100 µm (Figure 4A). To permit direct comparison of mesh 
mechanical properties with those of the tubular hydrogel-mesh composites, tubular mesh 
scaffolds with mean circumferential fiber orientation were prepared. Ring segments from 
the tubular mesh constructs were mechanically tested and displayed an average UTS of 
0.70 ± 0.24 MPa and an average tangential modulus of 0.92 ± 0.24 MPa. Figure 5A 
compares the circumferential stress-strain behavior of the tubular PEUUR electrospun 
mesh with that of a representative human coronary artery. Figure 5B illustrates the 
contribution of elastin and collagen to the arterial loading response, as determined by 
Roach and Burton (13). Examination of Figures 5A and 5B indicates that the 
circumferential mechanical response of the tubular mesh scaffolds agreed well with the 
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“high stiffness” segment of the coronary artery stress-stain curve and with the 
contribution of collagen to the arterial mechanical response. Similarly, mechanical 
testing of the selected PEG-fibrin hydrogel formulation revealed a stress-strain curve 
that closely mimicked the contribution of elastin to the “low stiffness” region of the 
arterial stress-strain curve (Figures 5A-B).  
 
Figure 4. Construct structural integrity and cell viability. (A) An SEM image of a single electrospun mesh 
layer illustrating fiber thickness and orientation. (B) An SEM image of a transverse cross-section through 
a hydrogel-electrospun mesh construct indicating effective bonding and interpenetration between the 
hydrogel and mesh layers. In preparation for SEM imaging, the inter-layer bond withstood dehydration 
(which differentially impacts hydrogel and mesh components) as well as multiple microwave cycles. (C) 
A higher magnification image of the boxed region of the hydrogel-mesh construct shown in (B). (D) A 
representative fluorescence image of LIVE (green)-DEAD (red) stained cells within the fibrin gel portion 
of the hybrid constructs at 24 h post-fabrication. As shown in (D), cells encapsulated within the fibrin 
hydrogel had not yet fully spread following 24 h of culture. The scale bars in (A)-(C) represent 10 µm and 
the scale bar in (D) represents 40 µm. 
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Figure 5. Arterial, PEG-fibrin, and PEUUR electrospun mesh mechanical responses. (A) A representative 
circumferential stress-strain response for human coronary artery, adapted from van Andel et al (12). In the 
present study, the PEUUR formulation and electrospinning conditions were selected to result in a mesh 
which would mimic the contribution of collagen fibers to the “high stiffness” region of the coronary artery 
stress-strain curve, as shown in (B). The PEG-fibrin hydrogel formulation was similarly selected to mimic 
the contribution of elastic fibers to the “low stiffness” region of the stress-strain curve, as illustrated in (B). 
(B) The circumferential tension-strain response of a human iliac artery and the respective contributions of 
elastin and collagen, adapted from Roach and Burton (13). The trypsin digested specimen represents the 
influence of the loss of elastin on arterial dynamics. Alternatively, the formic acid digested sample 
represents the impact of the removal of collagen fibers. 
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2.3.2 PEG-Fibrin-Mesh Construct Fabrication and Assessment of Cell Viability 
 Given the correspondence in mechanical responses described above, composite 
grafts were prepared using the selected PEURR electrospun mesh and PEG-fibrin   
formulation. In addition to providing the “low stiffness” response of the composite 
scaffold, the PEG-fibrin hydrogel was intended to act as an adhesive agent, effectively 
bonding successive mesh layers together. To serve as an effective bonding agent, the 
fibrin hydrogel should penetrate into the electrospun mesh layers. SEM imaging was 
therefore conducted to assess the microstructure of the PEG-fibrin mesh composites. The 
resulting images indicate that the chosen construct fabrication conditions supported the 
hydrogel-mesh interpenetration required for construct integrity and for the effective 
transfer of load between scaffold components (Figures 4B-C). To confirm the 
cytocompatibility of the extended exposure to thrombin, PEGDA, and photoinitiator 
associated with construct generation, the LIVE-DEAD assay was performed on scaffold 
segments (Figure 4D). These studies indicated a 24 h post-fabrication cell viability of 75 
± 2%, a level consistent with that observed following cell encapsulation within PEGDA 
gels (41). 
2.3.3 Assessment of PEG-Fibrin-Mesh Construct Mechanical Properties 
 To assess the potential of composite grafts to be implanted at the time of 
fabrication, the suture retention strength of the PEG-fibrin-mesh constructs was 
determined. These measures indicated an average suture retention strength of 1.16 ± 0.08 
N. In addition, the mechanical response of hybrid gel-mesh scaffolds to circumferential 
loading was characterized both at 24 h post-fabrication and following 16 days of total 
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culture. As illustrated in Figure 6, the composite constructs displayed a “J-shaped” 
stress-strain curve, with the region of “upturning” occurring at similar strains as for 
native human coronary artery (Figure 6 versus Figure 5A). In addition, the stress-strain 
behavior of the PEG-fibrin hydrogel and the electrospun mesh components correlated 
well with the “low stiffness” and “high stiffness” regions, respectively, of the composite 
construct stress-strain curve. Since mechanical mismatch between vascular grafts and 
native tissue over the range of normal physiological loading can result in aneurysmal 
failure, the average tangential modulus of the hybrid scaffolds was evaluated at a 
circumferential stress corresponding to normal physiological pressures (Figure 6). The 
average tangential modulus of the hydrogel-mesh constructs 24 h post-fabrication was 
0.48 ± 0.03 MPa, approximately 50% lower than the corresponding tangential modulus 
of the tubular mesh-only scaffolds. Similarly, the endpoint tangential moduli of the static 
and dynamic hybrid constructs were 0.57 ± 0.13 MPa and 0.57 ± 0.15 MPa, respectively, 
values statistically indistinguishable from that of the 24 h composite grafts. For the 
purpose of comparison, the tangential modulus represented by the human coronary 
artery stress-strain curve in Figure 5A was calculated to be ~0.34 MPa. 
In terms of tensile strength, the 24 h hydrogel-mesh constructs displayed an 
average UTS of 0.32 ± 0.06 MPa. This UTS value was approximately 50% of that of the 
tubular mesh scaffolds and likely reflects the fact that composite construct failure arises 
from breakdown of the mesh-hydrogel bonding rather than from internal mesh failure. 
The average endpoint UTS of the statically-cultured composite scaffolds was similar to 
that of the 24 h hybrid grafts at 0.28 ± 0.08 MPa. In contrast, the average UTS of 
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mechanically-conditioned scaffolds was 0.10 ± 0.06 MPa, or roughly 33% of the 24 h 
construct UTS (p = 0.048). 
 
 
Figure 6. A representative circumferential stress-strain response of a hydrogel-electrospun mesh scaffold 
relative to the mechanical responses of the individual construct components. The slope of the dashed line 
represents the tangential modulus of the composite constructs at physiological pressures.  
 
2.3.4 ECM and Cell Phenotype Analyses 
 In order to examine cell phenotype and ECM production within the PEG-fibrin-
mesh composites, competitive ELISA assays and immunohistology were performed. 
Although immunohistology indicated a similar staining intensity for SMC marker 
SM22α on a per cell basis in both static and dynamic constructs, marked differences in 
the distribution of stained cells were observed between these construct types (Figure 7). 
Since TGF-β1 treatment has been previously shown to induce > 90% of exposed 10T½ 
cells to express early- and mid-term SMC markers (38), the distribution of SM22α-
stained cells within the mesh layers could be taken as an indicator of the extent of cell 
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migration into the composite construct mesh. At the time of hybrid scaffold fabrication, 
cells were primarily localized at the mesh surface (Figure 7A), consistent with the initial 
mesh seeding conditions. Following 16 days of total culture, cell migration into the mesh 
layers of the static hybrid constructs tended to be limited to the first ~15 µm of the 
seeded surface of each mesh layer (Figure 7B). In contrast, the average dynamic 
scaffold exhibited cell migration into the first ~35 µm of the seeded surface of each 
mesh layer at 16 days of culture (Figure 7C).  
 
 
Figure 7. SM22α staining as an indicator of cell migration into the mesh layers of PEG-fibrin mesh hybrid 
scaffolds. (A)  A representative image of an SM22α-stained, transverse section through a composite 
scaffold at the time of composite construct fabrication. (B) The average observed extent of SM22α 
staining within a transverse section of a static, hydrogel-mesh composite construct following 16 days of 
total culture. (C) The average observed extent of SM22α staining within a transverse section of a dynamic, 
hydrogel-mesh composite construct following 16 days of total culture. The images reflect the fact that 
cryosections of the composite constructs failed to adhere to charged slides. The constructs therefore 
experienced significant mechanical stress during the immunostaining process which tended to result in the 
separation of individual construct layers. The scale bar in (A) applies to all images and represents 25 µm. 
The “lumen” label  associated with each image is intended to give orientation information and is not 
intended to imply that that particular surface contacted the lumen. 
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 ELISA results supported the similar degree of per cell SM22α expression in 
static and dynamic composite constructs that was indicated by immunostaining (Figure 
8). In addition, ELISA measures of the average per cell calponin h1 levels in the static 
and dynamic hybrid grafts could not be distinguished. Regarding ECM protein 
production, ELISA data indicated that collagen I, collagen III, and elastin were able to 
accumulate within both the static and mechanically-conditioned composite scaffolds 
(Figure 8). Immunohistological evaluation of collagens I and III supported these ELISA 
results and demonstrated that these newly synthesized ECM proteins were able to 
deposit within the mesh structure (Figure 9). 
 
 
Figure 8.  ELISA results for collagen I, collagen III, elastin, SM22α, and calponin h1 normalized to 
housekeeping protein GAPDH.  
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2.4 Discussion 
The aim of the current study was to investigate the potential of hydrogel-
electrospun mesh scaffolds for CABG applications. These composite scaffolds were 
generated by rolling a PEUUR electrospun mesh around an inner mandrel and 
subsequently bonding the juxtaposed mesh layers together using a fibrin-based hydrogel 
matrix. The underlying hypothesis of this work was that these composite scaffolds would 
exhibit key features of the individual mechanical response of each component, with the 
“low stiffness” behavior of the hybrid constructs being dominated by the hydrogel and 
the “higher stiffness” behavior being dominated by the mesh. These hybrid scaffolds 
would thereby more closely approach the biphasic mechanical response of native vessels 
than would electrospun mesh alone. Consistent with this hypothesis, circumferential 
mechanical testing of PEG-fibrin-mesh constructs revealed a “J-shaped” stress-strain 
curve similar to that of native human coronary artery which was not achieved by 
electrospun mesh-only grafts.  
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Figure 9. Representative images of transverse sections through statically- and dynamically-cultured 
composite constructs following immunostaining for collagen I and collagen III. Images of corresponding 
negative control sections (which received control IgG serum in place of primary antibody) are included for 
comparison. Observed detachment between adjacent mesh layers reflects the fact that cryosections of the 
composite constructs failed to adhere to charged slides. The constructs therefore experienced significant 
mechanical stress during the immunostaining process which tended to result in the separation of individual 
construct layers. The scale bar applies to all images and represents 25 µm. The “lumen” label associated 
with each image is intended to give orientation information and is not intended to imply that that particular 
surface contacted the lumen. 
 
In addition, the hybrid scaffolds appeared to retain the high suture retention 
strengths typical of electrospun mesh, displaying an average suture retention strength 
similar to that reported for mammary artery (~1 N) (23), a preferred coronary artery graft 
material (5). Thus, these results indicate that the hydrogel-mesh composite scaffolds 
have suture retention strengths sufficient for implantation at the time of preparation. The 
average tangential modulus of freshly prepared composite constructs at physiological 
pressures exceeded the target 0.20-0.40 MPa range associated with coronary artery by 
~20% (42). However, these hybrid scaffolds more closely mimic the tangential modulus 
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range of native coronary artery than do human saphenous vein grafts, another preferred 
coronary artery graft (5). Specifically, human saphenous vein displays a tangential 
modulus of ~2 MPa under similar testing conditions (23). In terms of tensile strength, 
the 24 h hybrid scaffolds exhibited an average circumferential UTS of 0.32 MPa, which 
is consistent with the ~0.37 MPa UTS measured for vertebral artery by circumferential 
ring tests (35). However, this average hybrid scaffold UTS is significantly lower than the 
~3.7 MPa circumferential UTS reported for human saphenous vein (23). Additional 
tuning of the material properties of the individual construct components and their 
cohesion may further improve the correspondence between the initial composite graft 
tangential modulus and UTS values and the respective target values. Alternatively, an 
“outer” sleeve could be incorporated into the construct design to increase construct UTS 
decoupled from vessel regional stiffness considerations (43). 
 The average endpoint tangential modulus of both the static and dynamic 
composite constructs remained similar to the 24 h values. Moreover, static constructs 
maintained the observed 24 h circumferential UTS values following prolonged culture. 
However, the inter-sample variation in tangential modulus and UTS within both the 
statically-cultured and the mechanically-conditioned treatment groups increased notably 
with time in culture. For instance, the standard error of the mean for the 24 h tangential 
modulus measures was ~6 % of the average value, whereas the standard error of the 
mean for the tangential modulus measures of the endpoint dynamic constructs was ~26 
% of the average value. In addition, extended cyclic distension was associated with a 
significant decrease in composite scaffold UTS relative to initial graft properties. Based 
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on visual comparison of the endpoint static and dynamic constructs prior to mechanical 
testing, the tangential modulus and UTS of the composite scaffolds appeared to be 
highly correlated with the integrity of the fibrin hydrogel bond with adjacent mesh layers. 
For static constructs, the increase in inter-sample variation in modulus and UTS relative 
to that of the 24 h constructs was therefore likely due, in part, to the degradation of the 
fibrin gel and/or mesh components and the associated reduction in gel-mesh bond 
integrity. In the mechanically-conditioned constructs, mechanical shearing between the 
electrospun mesh and hydrogel layers induced by repeated construct distension may 
represent an additional mechanism for reduction in the integrity of the fibrin-mesh bond. 
Increased cell matrix metalloproteinase expression upon cyclic distension may also be 
involved in the observed difference in UTS between static and dynamic hybrid grafts 
(44). It can be hypothesized that approaches to increase the strength of the inter-mesh 
adhesive bond, such as pre-treating the mesh to increase its hydrophilicity or soaking the 
mesh in fibrinogen solution prior to rolling, would increase long-term construct 
mechanical integrity.  
 Although increasing the hybrid scaffold inter-layer cohesion can be expected to 
prolong initial construct integrity, the maintenance of appropriate graft mechanical 
properties over the long-term requires cell infiltration throughout the construct layers 
and sufficient associated neomatrix accumulation. Present results suggested that cells 
were able to migrate through the mesh layers of the composite scaffolds. In addition, 
mechanical conditioning appeared to enhance cell motility, either by forcing repeated 
microstructural changes in the mesh and/or by inducing alterations in cell phenotype 
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(45). Similarly, ELISA and immunohistological data indicated that the composite 
scaffolds were able to support ECM accumulation. Although no differences in the levels 
of collagen type I, collagen type III or elastin were observed between static and dynamic 
constructs in the present study, this result may be due to the relatively low average 
strains (~2.5%, as estimated by the Bernoulli equation) experienced by the dynamic 
constructs. Specifically, previous literature indicates that strains exceeding 5% are 
generally necessary for alterations in SMC ECM production and phenotypic markers to 
be observed in vitro (46). Decreasing mesh thickness or fiber density (47) and/or 
employing vacuum and/or centrifugal seeding methods (48) may allow for increased cell 
penetration into the mesh layers, and therefore more even neomatrix distribution within 
the composite scaffolds.  
 Cumulatively, the present results suggest that hydrogel-electrospun mesh 
composites warrant further investigation as scaffolds for arterial tissue engineering. In 
addition, these hybrid scaffolds may have potential applicability in the regeneration of 
other soft tissues with biphasic loading responses, such as ligament. Although the 
PEUUR2000 formulation used herein has not been demonstrated to have an optimal 
degradation rate for vascular applications, the broad tunability of the elastic modulus, 
UTS, and degradation rate of polyurethane-based elastomers can be exploited to identify 
formulations which display desired mechanical properties as well as appropriate 
degradation rates. Our future CABG hydrogel-mesh composite studies will also focus on 
modifying the fibrin gel composition and composite construct fabrication methods to 
improve inter-layer cohesion. 
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CHAPTER III  
REGULATION OF SMOOTH MUSCLE PHENOTYPE  
BY EXTRACELLULAR MATRIX PROTEIN IDENTITY 
 
3.1 Introduction 
Blood vessel replacements are often necessary in the treatment of advanced 
atherosclerosis, aneurismal and peripheral vascular disease, etc. In the US alone, more 
than 500,000 coronary artery bypass procedures are performed annually. Tissue 
engineering represents a potential means to construct functional grafts when compared to 
the limited availability of autologous saphenous veins and relatively poor elasticity and 
low compliance of synthetic materials (mainly Dacron and polytetrafluoroethylene) (6). 
To improve the designing of tissue engineering vascular grafts, a great challenge is to 
obtain a well organized and functional medial layer which is mainly comprised of 
mature SMCs. The utilization of mesenchymal progenitor cells with given differentiation 
conditions to obtain SMC has become one of the promising ways to overcome the 
challenge (49, 50). In order to differentiate the mesenchymal progenitor cells towards 
SMC, soluble growth factors such as transforming growth factor-beta1 (TGFβ1), 
ascorbic acid, and insulin are widely used (51-53). Although the inductions of these 
growth factors are very efficient and stable in vitro, there are still some drawbacks of 
them especially in tissue engineering applications. The growth factors are too expensive 
to be used in large scale applications, and the growth factors have undesired effects on 
neighboring tissue. Also, soluble growth factors are difficult to control in tissue 
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engineering constructs. Recently A. J. Engler et al. showed that the matrix stiffness can 
direct stem cell lineage specification with similar effect as growth factors and 
furthermore soluble induction factors tend to be less selective than matrix stiffness in 
driving specification, and cannot reprogram MSCs that are pre-committed for weeks on 
a given matrix (54). And G.E Plopper’s group has shown that only the ECM can be 
sufficient to induce progenitor cells to osteoblasts (55, 56). Moreover, C. Chen’s group 
also showed the influence of ECM on stem cell fate through physical interactions with 
cells such as the control of cell geometry, ECM geometry/topography, ECM mechanical 
properties (57). From all the previous reports, it is still unclear which properties of the 
ECM are most critical in terms of determining the cell fate of progenitor cells. In this 
project, we will examine the bioactivity identity of given ECM components to verify if it 
is the dominant stimuli in cell-material interactions. 
In the process of vasculogenesis, it is understood that the assembly of the vessel 
wall from its cellular and ECM components is a critical process in the development and 
maturation of the vertebrate vascular system (58). Previous literature has demonstrated 
that fibronectin and laminin play significant roles in this process (58, 59). Fibronectin 
plays a role in the early migratory events of vessel wall development and correlates the 
production of laminin, contained in the basement membrane, to vessel wall maturation 
(58, 60). The absence of fibronectin and collagen type I will cause the disruption of 
endothelial cell tubes (61). During vasculogenesis, the dynamic composition of the ECM 
also brings attention to how the ECM functions in mural cells differentiation. The 
transition of ECM composition from fibronectin and collagen type I to laminin and 
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collagen type IV when the mural cells start differentiation could imply that these 
molecules may have some impact on inducing and/or maintaining the SMC phenotypes 
(62). Recently it has been shown that when the mural cells undergo differentiation, fibrin 
can also be found around the leaky vessel precursors, which gave rise to the hypothesis 
that fibrin may be involved in SMC differentiation process. Also, it has been 
demonstrated that adult human bone marrow progenitor cells can induce a dynamic self 
organization process to create vascular structures within 3D fibrin matrices (63). In this 
project we chose collagen type IV, fibrinogen, fibronectin, laminin as the biochemical 
stimuli and RGDS as the control. 
In order to study the differentiation of the progenitor cells, we choose mouse 
mesenchymal smooth muscle progenitor 10T½ cells, which are well characterized 
multipotent embryonic fibroblasts. 10T½ cells are very sensitive to both the post 
confluence inhibition of cell division, and the microenvironment, which will induce this 
mesenchymal cell line to differentiate into different cell types, e.g. smooth muscle cell 
(64), cartilage lineage (65), etc. Unlike the human mesenchymal stem cells, which are 
very unstable in different culture systems and vary from the different donors, 10T½ cells 
give more reliable and reproducible response to the experimental microenvironment. In 
the past few decades, the 10T½ cells have been one of the most studied systems for the 
investigation of smooth muscle cell differentiation and the associated cell signaling 
pathway. Sato and his colleagues (66) demonstrated the activation mechanism of 
TGFβ1-induced smooth muscle cell-genes in 10T½ cells. Wang and his colleagues (67) 
investigated the transactivation of cardiogenic genes in 10T½ fibroblasts. S.C Lien et al 
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(64) have shown that Phosphatidylinositol 3-kinase/Akt pathway was involved in 
TGFβ1-induced phenotypic modulation of 10T½ cells to smooth muscle cells. However, 
the reports on the 10T½ cells differentiation in three dimension culture system are 
limited. Recently the importance of studying cell behavior in three dimension culture has 
been emphasized because essential cellular functions that are present in tissues are 
missed by 'petri dish'-based cell cultures. Two dimensional culture limits the potential to 
predict cellular responses of real organisms in vitro (68). This project aims to give us 
insight into the differentiation of progenitor cells in three dimension culture systems.  
Over the past three decades, a number of hydrogels have been developed, 
differing in structure, composition, and properties. Due to the hydrophilic but 
crosslinked structure, hydrogels can swell large quantities of water without the 
dissolution of the polymer, thus giving them physical characteristics similar to soft 
tissues (69). 
 
Figure 10.  Molecular structure of poly(ethylene glycol) diacrylate (PEGDA). 
 
Poly(ethylene glycol) (PEG) hydrogel is one of the most common used 
biomaterials because of its excellent biocompatibility, non-biofouling and easy 
fabrication. In recent years, many researchers have applied PEG hydrogel to diverse 
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aspects in tissue engineering including drug delivery (70), tissue restoration (6, 71-73), 
and cell-materials interactions (74, 75). 
In the present work, PEGDA based hydrogel was functionalized by ECM 
proteins, such as fibronectin, fibrinogen, laminin and collagen type IV to create a three 
dimensional construct with encapsulated smooth muscle precursor cells 10T½ cells to 
study the impact of ECM protein identity on regulation of smooth muscle phenotype. 
 
3.2 Materials and Methods 
3.2.1 Poly(ethylene glycol) (PEG) Hydrogel Preparation and Cell Encapsulation 
Poly(ethylene glycol) (PEG) (MW10000, Fluka) was diacylated using the 
common method described previously (75) by combining 0.1 mmol/ml dry PEG, 0.4 
mmol/ml acryloyl chloride, and 0.2 mmol/ml triethylamine in anhydrous 
dichloromethane (DCM) and stirring under argon overnight. The resulting solution was 
washed with 2 M K2CO3 and separated into aqueous and DCM phases to remove HCl. 
The DCM phase was subsequently dried with anhydrous MgSO4, and PEGDA was 
precipitated in diethyl ether, filtered, and dried under vacuum. The molecular structure 
of PEGDA is shown in Figure 10. 
ECM molecules, such as the fibronectin (MP Biomedicals) , fibrinogen (MP 
Biomedicals), collagen type IV(Sigma) and laminin (Sigma), were chemically linked to 
the ACRL-PEG-NHS (MW 3400, Nektar) according to the protocol described 
previously (76). The reaction between the NHS and the primary amine in the proteins is 
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shown in Figure 11. Arg-Gly-Asp-Ser (RGDS), the cell binding peptide was also 
PEGylated as control. 
 
Figure 11. Incorporation of peptides and/or proteins containing α-amine to ACRY-PEG-NHS. (69, 77) 
 
10T½ cells (Passage 3~4) were suspended in the precursor solution containing 
10% of 10k diacrylated PEG (PEGDA), 3mg/ml acetophenone and 0.5mg/ml ACRL-
PEG-Proteins in HEPES buffered saline (HBS; 10 mM HEPES, 100 mM NaCl, pH 7.4), 
at a cell density of 1 million/ml. Then the precursor solution was poured into glass 
cassette with 0.5 mm spacers and UV irradiated (UVP model B-100SP, 10mW/cm2, 365 
nm) for 3 minutes on each side. The cured hydrogels with encapsulated cells were 
removed from the cassettes and then immersed in phosphate buffered saline (PBS, pH7.4) 
plus 100 IU/mL penicillin, 100 µg/mL streptomycin and 250ng/mL Amphotericin B 
(MP Biomedicals). The hydrogels were then transferred to the Dulbecco's Modified 
Eagle Medium (DMEM, Mediatech) supplemented with 10% heat treated fetal bovine 
serum (dFBS, HyClone) and 100 IU/mL penicillin, 100 µg/mL streptomycin and placed 
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in the incubator with 5% CO2. The media was changed every other day. Samples were 
taken at 1 week time point. 
3.2.2 Cell Chip 
Agilent 2100 analyzer with the Cell Fluorescence LabChip®Kit were used to 
characterize the cell phenotype. 10T½ Cells (approximately 0.2million per staining) 
were collected and washed with cold D-PBS once and resuspended in staining buffer 
(PBS supplemented with 1% BSA) to reach 2million/ml. 2uM of the calcein was used to 
stain the live cells for 30mins at room temperature in dark. The cells were washed twice 
before adding the antibody. Staining was performed by adding to the cells 1ug of the 
primary antibody (SCBT unless stated specifically) and appropriate isotype controls 
(SCBT, Jackson Imunoresearch) diluted in 100ul of the staining buffer. All samples 
were incubated on ice for 30mins. Fluorescence-labeled secondary antibodies were used 
to label the cells with 1:50 dilution in staining buffer and the incubation was done on ice 
for 30mins avoiding light. Labeled cells were spun down and resuspended in 30ul of the 
cell buffer and 10ul of the sample were loaded to the cell chip according to the 
manufacturer. Antibody used: Anti-CD105 (MJ7/18), Anti-CD44 (1M7), Anti-CD34 
(MEC14.7), Anti-CD45 (30-F11), Anti-mouse-IgG-633 (Invitrogen), Anti-rat-IgG-
Dylight 649 (Jackson Immunoresearch). 
3.2.3 Quantitative Protein Expression Analyses 
Sample proteins were isolated using a modification of a procedure validated by 
Hummon et al (78). In brief, the phenol-chloroform phase resulting from Trizol-based 
RNA extraction was mixed with ethanol to precipitate residual DNA. The resulting 
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phenol-ethanol phases for all constructs in a given ECM component group (e.g., all 
Fibronectin constructs) were combined and transferred to a 3.4 kDa SnakeSkin dialysis 
membrane (Pierce). The solutions were dialyzed for ~60 h at 4 °C against an aqueous 
solution of 0.1% sodium dodecyl sulfate (SDS), with buffer exchange every ~18-20 h. 
By the end of third 18-20 h dialysis period, the samples had partitioned into three phases: 
(1) a supernatant, (2) a globular mass, and (3) a colorless, viscous liquid. The globular 
mass, containing the bulk of sample proteins, was resuspended in PBS containing 0.5% 
SDS and 1% Triton X-100. 
Competitive Enzyme-linked immunosorbent assay (cELISA) was used to analyze 
the protein expression quantitatively. In brief, approximately 200ng of the given peptide 
was coated in the EIA high binding plate (Corning) at 4°C overnight. The second day, 
standards and the samples were diluted in PBS containing 0.05% Tween20 (Sigma) and 
3% bovine serum album (BSA) (Fisher) and competition between the free antigen in 
solution and the antigen on the coated well was formed by mixing the samples and/or the 
standards with the primary antibody solution in given dilution at room temperature for 1 
hour before loading the mixture to the coated wells for another 1 hour. The bound 
primary antibody was detected by applying donkey anti-mouse/anti-goat/anti-rabbit-IgG-
HRP (Jackson Immunoresearch), which is also diluted in 3% BSA in PBST, followed by 
application of 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS, sigma). 
The color development was monitored with a microplate reader at the wavelength of 410. 
All antibodies and peptides used were from Santa Cruz unless described specifically. 
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3.2.4 Statistical Analyses 
All data are reported as mean ± standard error of the mean. Comparisons among 
hydrogel treatment groups were conducted using ANOVA and Tukey’s post-hoc test 
(SPSS software), p < 0.05.  
 
3.3 Results 
3.3.1 Characterization of the Initial Phenotype of 10T½ Cells 
Since the 10T½ cells have the potential to undergo differentiation into different 
cell lineages, such as smooth muscle cells (64), chondrocytes, osteoblasts (65, 79) and 
etc, cell characterization at the initial status needs to be performed to confirm that the 
cells are undifferentiated. A cell fluid-based microchip was used to analyze the cell 
phenotype using 2100 bioanalyzer (Agilent) with similar principle of flow cytometry 
(80). To verify the phenotype of 10T½ cells at the start point, surface markers such as 
CD105, CD34, CD44, and CD45 were tested before the cell encapsulation. As is shown 
in Figure 12 (A-D), the 10T½ cells showed positive staining of CD105 and CD44, but 
the cells didn’t express detectable level of CD34 and CD45, which demonstrated that the 
cells were not differentiated according to previous literature (81, 82). 
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Figure 12. Immunophenotyping of 10T½ cells by cell chip based flow cytometry. Single parameter 
histograms showed the relative fluoresecence intensity of staining and the cell counts. Isotype controls 
were included to show the background fluorescence, as is shown in shaded peaks. The open peaks 
represented the common MSC markers: CD45, CD44, CD45, CD105. The 10T½ cells were positive for 
CD44, and CD105, but negative for CD34 and CD45. Gate was set up according to calcein stain for live 
cells.  
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3.3.2 Assessments of Expression of Differentiation Markers 
To assess the 10T½ cells differentiation under the impact of the different ECM 
proteins, ELISA was performed to monitor the differentiation markers of different cell 
lineages, namely, SM22α for SMCs, collagen type II for chondrocytes, osteocalcin for 
osteoblasts, and A-FABP for adipocytes. After 7 days of culture, it was demonstrated 
that within the protein concentration range used in this study, the impact of ECM protein 
identity was relatively weak on mouse smooth muscle precursor cell differentiation 
(Figure 13). Fibrinogen, fibronectin, collagen type IV, laminin showed no preference in 
myogenesis in terms of SM22α expression relative to the RGDS control (Figure 13A). 
Collagen type II expression also showed great consistency across all the formulations 
(Figure 13B), suggesting that chondrogenesis was not altered by these ECM proteins 
alone to a detectable level. However, A-FABP and osteocalcin expression showed weak 
difference among groups. In the fibrinogen and fibronectin containing hydrogels, late-
term adipogenic marker A-FABP was reduced relative to collagen IV gels and RGDS 
control gels, and compared to laminin functionalized hydrogel, the A-FABP expression 
in fibrinogen gel was significantly decreased (p=0.033) (Figure 13C).  In fibronectin 
gels, osteocalcin expression was relatively lower than other gels and moreover, the 
difference between fibronectin gels and laminin gels were statistically significant 
(p=0.014) (Figure 13D).  Although there are some significant differences in 
differentiation marker expressions under the impact from ECM proteins, the difference 
was not strong enough to be dominant.  
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Figure 13. Assessment of 10T½ cells differentiation under the stimuli from different ECM proteins after 7 
days by comparison of relative expression of the differentiation markers for different lineages. Namely, 
SM22α for SMCs, collagen type II for chondrocytes, osteocalcin for osteoblasts, and A-FABP for 
adipocytes. Asterisk (*) indicates significant difference, p<0.05. All data of fibrinogen (FG), fibronectin 
(FN), collagen type IV (ColIV), laminin (LN) have been normalized to the corresponding RGDS control. 
 
3.3.3 Analysis of Integrin Profile  
Integrins are the primary mediators of cell-ECM interactions and this family of 
proteins exert profound control over cells (83). The integrins are necessary in mediating 
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both mechanical and chemical signals from the ECM. A growing body of literature 
demonstrated that integrins play important roles in cell proliferation and cell 
differentiation (84). In the present work, we analyzed the expression profile of integrin 
α1, integrinα3, integrin α5, and integrin α6, because all of them are important in cell-
ECM interactions, and have specificity over different ECM proteins. For example, 
integrin α1 is specific for collagen type I, collagen type IV and laminin; integrin α3 is 
specific for laminin, collagen and fibronectin, while integrin α5 only recognize 
fibronectin; and integrin α6 serves as a specific laminin receptor (83).  
Fibronectin, fibrinogen, collagen type IV and laminin seem to have limited 
potency to regulate expression of integrin α1 (Figure 14A), integrin α3 (Figure 14B) 
integrin α5 (Figure 14C), and integrin α6 (Figure 14D), since no significant difference 
in relative expression has been detected across the hydrogel formulations. However, 
integrin expression can be correlated to the smooth muscle phenotypic modulation, and 
in particular, integrin α1 is transcriptionally regulated in a SMC phenotype-dependent 
manner (85). As is shown in Figure 13A and Figure 14A, the SM22α expression shared 
great consistency with integrin α1 expression, which further demonstrated the limited 
influence of ECM protein on SMC phenotype. Although the expression level of integrin 
α3 was not altered within different ECM functionalized gels, the expression levels were 
significantly elevated compared to cell cultured in poly styrene flask (RGDS p=0.049, 
LN p=0.007). This might be because of the different mechanical property between 
hydrogel and culture flask, and also due to the difference between cellular responses in 
2D and 3D cell culture systems. 
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Figure 14. Integrin profiling of the encapsulated 10T½ cells after 7 days. Relative expression of integrin 
α1, α3, α5 and α6 were measured and compared across formulations. Data from the encapsulated cells 
have been normalized to corresponding data of 10T½ cells cultured in poly styrene culture flask (PS). 
Asterisk (*) indicates significant difference, p<0.05, between PS sample and LN sample; # significantly 
different between PS sample and RGDS sample, p<0.05. 
 
3.3.4 Evaluation of Cell Signaling Activation 
From the ELISA results of differentiation markers and integrins, the ECM 
protein identity showed limited impact on regulating the expression of differentiation 
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markers in 10T½ cells. To further study the interactions between smooth muscle 
precursor cells and ECM proteins, the activation of important cell signaling switches was 
investigated. MAP (mitogen-activated protein) kinases play a significant role in cell 
adhesion and spreading, cell differentiation and apoptosis (86). The interactions of 
integrins and MAP kinases have been well studied in an extensive body of literature (87, 
88). 
Given the important and ubiquitous involvement of MAP kinases in the 
regulation of gene expression and cellular differentiation, we tested the activation of two 
MAP kinases, JNK, and ERK. Figure 15 shows that the activation of ERK1/2 and JNK 
was relatively consistent across the formulations. Although the activation of ERK1/2 and 
JNK showed limited difference among the groups, they showed very similar trend to 
some of the differentiation marker expression, for example, pERK1/2 and A-FABP, 
which is consistent with the correlation between the modulation of adipogenic phenotype 
and the MEK/ERK signaling cascades (89). 
 
3.4 Discussion 
The aim of this present study was to examine the impact of ECM protein identity 
on regulation of smooth muscle phenotype. Smooth muscle precursor cell, 10T½ cells 
were encapsulated into ECM protein functionalized hydrogel and cultured for 7 days 
with normal growth media without additional growth factor. The hydrogels have the 
appropriate mechanical property for smooth muscle cell differentiation (54). But no 
significant impact of ECM protein identity on smooth muscle differentiation has been 
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detected within our experiment conditions. We have examined the expression of 
differentiation markers, activation of the cell signaling switches, and expression of the 
 
Figure 15. Evaluation of MAP kinases activation under the stimuli from different ECM proteins after 7 
days by comparison of relative levels of the phosphorylated  ERK1/2 and JNK. Anti-p-ERK 1/2 (Thr 
202/Tyr 204), and anti-p-JNK (Thr 183/Tyr 185) antidbodies were used in the ELISA. Data of RGDS 
control was used for normalization. 
 
surface adhesion receptors. Surprisingly to us, the impact of the ECM proteins identity 
was quite limited in all three aspects. To support our conclusion, a previous work done 
by Gong and Niklason(90) also showed that SMC early differentiation marker smooth 
muscle α-actin was not altered in human mesenchymal stem cells cultured on collagen 
type IV, fibronectin and laminin matrix, while the mid-term SMC marker calponin 
stayed the same on collagen and fibronectin but slightly decreased on laminin matrix. In 
contrast to our finding, Hedin et al indicated that fibronectin can promote a synthetic 
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phenotype while, laminin and collagen type IV helps maintain contractile phenotype of 
arterial SMCs (91), this could be due to the difference between the nature of mature 
SMCs and smooth muscle progenitor cells. Moreover, their work was done in petri-dish 
based 2D cell culture system, while our research focused on 3D hydrogel system, which 
could be a superior mimic of nature microenvironment (92).   
It seems the ECM protein identity is a weak variable in driving progenitor cell 
differentiation at least at the studied concentration, although we found a promising 
repression of osteogenesis and adipogenesis by fibronectin content (Figure 13C, D). The 
limitation may come from the limited concentration range used in the study, and the fact 
that vasculogenesis is a sequence, but we are not following the sequence, as we only 
examine individual components.  
To our knowledge, this is the first time that phenotypic regulation of smooth 
muscle progenitor cells by ECM protein identity has been studied in a controlled manner 
in 3D hydrogel system. By introducing PEGDA hydrogel system, we could rule out the 
variation of mechanical property across formulations because the modulus and mesh size 
were determined mainly by the PEGDA content. Utilization of 3D culture system helps 
mimic the real micro environment for tissue growth and induce more native cellular 
behavior than the typical 2D culture (92). Although we didn’t observe a strong impact of 
ECM protein on smooth muscle differentiation, the platform we designed for this study 
could still be expanded with other biochemical stimuli to investigate cellular behaviors 
in three-dimensional scaffolds. 
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CHAPTER IV 
REGULATION OF SMOOTH MUSCLE PHENOTYPE BY 
GLYCOSAMINOGLYCAN IDENTITY* 
 
4.1 Introduction 
As the predominant cell type found in the arterial wall, smooth muscle cells 
(SMCs) are believed to play essential roles in the structural and functional integrity of 
the vessel (93). In contrast to most cell types that experience terminal differentiation, 
SMCs retain remarkable plasticity in phenotypic modulation in response to local 
microenvironmental stimuli (94). An extensive body of literature dictated that SMC 
phenotypic regulation showed great influence in arterial injury and cardiovascular 
disease. For example, medial SMCs expressed osteogenic and chondrogenic marker 
proteins, such as alkaline phosphatase, type II collagen has been reported in calcified 
blood vessels (93, 95, 96). The conversion of SMCs from a contractile phenotype to a 
synthetic phenotype has also been reported in atherosclerosis (97). To improve our 
design of TEVG and the associated biomaterials, a comprehensive understanding of cell 
material interactions in terms of inducing appropriate SMC phenotype while repressing 
the undesired diseased phenotype would provide important clues. 
Coronary artery disease is a leading cause of death in the United States (98) and  
_______ 
*Reprinted with permission from “Regulation of Smooth Muscle Cell Phenotype by 
Glycosaminoglycan Identity” by X. Qu, A.C Jimenez-Vergara, D.J. Munoz-Pinto, D. 
Ortiz, R.E. McMahon, D Cristancho, S. Becerra-Bayona, V. Guiza-Arguello, K.J. 
Grande-Allen, M.S. Hahn, 2011.  Acta Biomaterialia, 7(3), 1031-1039, Copyright [2010] 
by Acta Materialia Inc. Published by Elsevier Ltd. 
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develops when excess cellular and ECM components build up in the coronary arteries 
through the process of atherosclerosis (10, 99, 100). Until recently, it was generally 
believed that the extracellular lipids associated with early atherosclerosis originated from 
dead foam cells derived from invading macrophages. However, it is now recognized that 
this early accumulation of lipids precedes macrophage infiltration and instead arises 
primarily from enhanced lipoprotein retention by the ECM of the arterial intima (10, 99, 
100). In fact, recent studies indicate that ionic interactions between the negatively-
charged glycosaminoglycan (GAG) side chains of intimal proteoglycans (PGs) and the 
positively-charged apolipoprotein residues of low density lipoproteins (LDL) are critical 
to early atherosclerotic lipid retention (101-103). 
As arterial LDL loading increases in atherogenesis, macrophages and smooth 
muscle cells (SMCs) increasingly infiltrate into the intima, followed by the appearance 
of foam cells (10). Although foam cells were long considered to arise exclusively from 
macrophages, it is now known that SMCs form a significant portion of the foam cell 
population (104, 105). The transition of SMCs to foam cells is marked by the acquisition 
of macrophage-like behaviors, such as scavenger-receptor uptake of LDL (106, 107), 
and/or by the acquisition of adipocyte-like properties, including expression of adipocyte 
fatty acid-binding protein (A-FABP) (105). Although it is recognized that GAG 
retention of lipoproteins is a key event in SMC foam cell formation (10), the extent to 
which specific GAG types contribute to this process is relatively poorly understood. 
Thus, the present work was designed to explore the impact of GAG identity on SMC 
phenotype using a scaffold environment intended to be mimetic of early atherosclerosis. 
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Specifically, the influence of chondroitin sulfate C (CSC), dermatan sulfate (DS), and an 
intermediate molecular weight hyaluronan (HAIMW, ~400 kDa), were examined, as the 
levels and/or distribution of each of these GAG types are altered in early atherosclerosis 
(10, 108-113). 
To generate culture conditions mimetic of early atherosclerosis, a poly(ethylene 
glycol) diacrylate (PEGDA) hydrogel was selected as the base scaffold into which 
desired GAG signals were conjugated. PEGDA gels have several properties which make 
them appropriate for the present studies. First, pure PEGDA hydrogels function as 
biological “blank slates” in that they do not significantly adsorb bioactive plasma 
proteins or intrinsically promote cell adhesion (114). Thus, hybrid PEGDA-GAG gels 
permit the defined investigation of GAG identity on SMC behavior. In addition, the slow 
degradation rate and high crosslink density of PEGDA gels force encapsulated cells to 
take on rounded/stellate morphologies with limited cell-cell interactions (115, 116). 
These particular characteristics of PEGDA hydrogels are generally considered 
undesirable for the study of normal SMC function. However, they are appropriate for 
atherosclerotic-mimetic environments, since atherosclerosis-induced changes are 
associated with SMCs taking on rounded/stellate morphologies (117-119) with limited 
intercellular gap junctions (120). Finally, the dense crosslinking and slow degradation 
rate of PEGDA gels prevent cell-mediated hydrogel contraction and the associated 
changes in scaffold material properties which can confound interpretation of cell 
responses (115).  
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In the present work, porcine SMCs were encapsulated in PEGDA hydrogels 
containing 0.1 wt% GAG, a concentration selected to be consistent with GAG levels in 
the arterial tissue (109, 121). A 10 wt% 10 kDa PEGDA hydrogel was chosen for the 
base-scaffold in order to mimic the modulus of lipid-rich regions of grade II 
atherosclerotic plaque (122). Following 14 and 35 days of culture, SMC phenotype in 
each formulation was assessed biochemically and histologically.  
 
4.2 Materials and Methods 
4.2.1 Polymer Synthesis and Characterization   
PEG-Diacrylate Synthesis. PEGDA was prepared as previously described (123) 
by combining 0.1 mmol/ml dry PEG (10 kDa, Fluka), 0.4 mmol/ml acryloyl chloride, 
and 0.2 mmol/ml triethylamine in anhydrous dichloromethane (DCM) and stirring under 
argon overnight. The resulting solution was washed with 2 M K2CO3 and separated into 
aqueous and DCM phases to remove HCl. The DCM phase was subsequently dried with 
anhydrous MgSO4, and PEGDA was precipitated in diethyl ether, filtered, and dried 
under vacuum. Extent of PEG diacrylation was determined by 1H-NMR to be ~70%. 
Synthesis of Methacrylate-Derivatized CSC and DS. In order to conjugate 
specific GAGs within the PEGDA-based hydrogel networks, each GAG type was 
methacrylate-derivatized according to standard protocols (124). CSC (~50 kDa; 6.4 wt% 
Sulfur; Sigma), and DS (~41.5 kDa; 6.1 wt% Sulfur; Sigma) were selected to have 
molecular weights (MWs) consistent with those observed in atherosclerotic tissue (108, 
121). The respective sulfur contents of these GAG chains indicated that, on average, the 
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disaccharide units composing the employed CSC and DS had a charge-density 
associated with mono-sulfation.  
The GAGs were dissolved in dIH2O to achieve a 1 wt% final concentration, and 
the pH of each solution was adjusted to 8.0. A 10 fold molar excess of methacrylic 
anhydride (Polysciences) was added per disaccharide unit. Each reaction was allowed to 
proceed under constant stirring at 4 °C, with the solution pH being maintained at ~8.0 by 
periodic addition of 5 M NaOH. The product of each reaction was precipitated twice into 
chilled ethanol 95%, dialyzed against dIH2O for 48 h, and lyophilized. The extent of 
methacrylate-derivatization was characterized by 1H-NMR to be ~1.0-1.6%. These levels 
of methacrylate-derivatization have been previously shown to negligibly alter observed 
cell responses (115, 124-128). 
Synthesis of Methacrylate-Derivatized Intermediate Molecular Weight HA. 
Recent studies indicate that atherosclerotic vessels contain two primary HA populations, 
one with MW > 1x103 kDa, which is also present within normal tissue, and a second 
with MW ~340 kDa, which appears to be specific to atherosclerotic tissue (108, 113). To 
generate HA appropriate for the examination of atherosclerotic conditions, high MW HA 
(HAHMW, Streptococcus equi, MW ~1.65x103 kDa; Fluka) was first methacrylate-
derivatized as above. The purified product was then dissolved at 1 mg/mL in PBS 
containing 0.05% sodium azide and 5 U/ml hyaluronidase IV-S (H3884, Sigma). 
Following incubation at 37 °C overnight, the enzyme was heat-inactivated. The resulting 
digestion product (HAIMW-MA) was dialyzed against dIH2O for 48 h and lyophilized. 
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The mean MW of the isolated HAIMW-MA was determined to be ~400 kDa, with a 
polydispersity of ~1.3 using gel permeation chromatography (Viscotek).   
Synthesis of Acrylate-Derivatized Cell Adhesion Peptide. Cell adhesion 
peptide RGDS (American Peptide) was reacted with acryloyl-PEG-N-
hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, Nektar) at a 1:1 molar ratio for 2 h in 
50 mM sodium bicarbonate buffer, pH 8.5 (116). The product (ACRL-PEG-RGDS) was 
purified by dialysis, lyophilized, and stored at -20 ºC until use.  
4.2.2 Characterization of Hydrogel Properties  
Hydrogel Initial Water Uptake. To compare initial hydrogel water uptake 
across formulations, the initial weight (Wi) of each gel was determined immediately 
following polymerization, after which the gels were submerged in media. After 24 h, the 
swollen weight (Ws) of each gel was measured. The equilibrium water uptake (S) was 
calculated as: 


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
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WS
.  This information was used to estimate the increase in 
hydrogel volume due to swelling, data which were then used to compare post-swelling 
GAG levels across gels. 
Average Mesh Size. PEGDA hydrogel mesh size cannot be visualized using 
standard techniques such as scanning electron microscopy (SEM) (129). In the present 
study, hydrogel mesh size was characterized via a series of dextran diffusion 
experiments based on an adaptation of the methodology of Watkins et al.(130) To avoid 
charge–charge interactions between the diffusing dextrans and the GAG chains in the 
hydrogel network, fluorescently-labeled, charge-neutral dextrans were employed. 
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In brief, PEGDA-GAG hydrogels were prepared and allowed to swell overnight 
at room temperature in PBS containing 0.05% azide (PBS-azide). 8mm diameter discs 
were cored from each hydrogel formulation. Fluorescently-labeled, charge-neutral 
dextrans (40 kDa and 70 kDa, Invitrogen) were dissolved at 0.05 mg/mL in PBS-azide 
and added at 0.5 mL per hydrogel disc (3 discs per dextran MW). Dextran solutions were 
allowed to diffuse into the hydrogels for 24 h at room temperature. Each gel disc was 
gently blotted and transferred to 0.5 mL fresh PBS-azide. Dextran that had penetrated 
into the hydrogels was then permitted to diffuse out into the surrounding solution at 
room temperature. After 24 h, the fluorescence of the PBS-azide solution surrounding 
each disc was measured at ex/em 528/590. Dextran standard curves were used to convert 
each fluorescence signal to a concentration. For each hydrogel formulation, the 
measured concentration readings for each dextran MW were divided by gel thickness 
and then plotted versus dextran hydrodynamic radius (131). The area (A) under the 
resulting curve served as a quantitative indicator of hydrogel permissivity over the 
hydrodynamic radii range assayed. For the purposes of comparison, the calculated area 
values for CSC and DS gels were normalized to that of the HAIMW gels to yield a relative 
mesh size value:




HA
x
x A
A~ξ
. 
Hydrogel Permissivity to LDL. To confirm the ability of LDL molecules to 
diffuse into the hydrogel networks, three gels from each formulation were exposed to a 
50 µg/mL solution of fluorescently-labeled LDL (Invitrogen) overnight at room 
temperature. Following 24 h, the levels of LDL which had diffused into the hydrogel 
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networks were examined using confocal microscopy and compared to control gels which 
had not been exposed to LDL.   
Comparison of GAG LDL Retention. To assess differences in the LDL-binding 
capacity of the various GAG-laden hydrogels, samples which had been exposed 
overnight to fluorescently-labeled LDL were transferred to a solution of fresh PBS-azide. 
Over a period of 24 h, the surrounding PBS solution was exchanged twice, after which 
the hydrogels were transferred to fresh PBS-solution for fluorescence imaging.  
4.2.3 Cell Culture  
Cryopreserved aortic SMCs (Cell Applications) isolated from pigs, a common 
animal model for vascular SMC physiology (132, 133), were thawed and expanded in 
monolayer culture between passages 4-8. Prior to encapsulation, cells were maintained at 
37 ºC/5% CO2 in Dulbecco’s Modified Eagles’ Media (DMEM, Hyclone) supplemented 
with 10% fetal bovine serum (FBS, Hyclone), 1 ng/mL bFGF (BD Biosciences), 100 
mU/mL penicillin and 100 mg/L streptomycin (Hyclone).  
4.2.4 Cell Encapsulation and Hydrogel Maintenance   
Hydrogels were fabricated by preparing precursor solutions containing 100 
mg/mL 10 kDa PEGDA, 1 mg/ml of methacrylate-derivatized GAG, and 1 μmol/ml 
ACRL-PEG-RGDS in HEPES buffered saline (HBS; 10 mM HEPES, 150 mM NaCl, 
pH 7.4). The concentration of GAG was selected to be consistent with physiological 
levels in arterial tissue (109). In addition, the 100:1 weight ratio of PEGDA to GAG was 
chosen to ensure that the degradation rate, modulus, and initial mesh structure of each 
hydrogel network would be dominated by PEGDA (115). A 300 mg/ml solution of UV 
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photoinitiator 2,2-dimethoxy-2-phenyl-acetophenone in N-vinylpyrrolidone was added 
at 1% to each precursor solution. SMCs were harvested and resuspended in the filter-
sterilized precursor solutions at ~1x106 cells/mL. The cell suspensions were then poured 
into molds composed of two glass plates separated by 0.5 mm polycarbonate spacers and 
polymerized by 2 min exposure to longwave UV light (Spectroline, ~6 mW/cm2, 365 
nm). The hydrogel slabs were transferred to Omnitrays (Nunc) fitted with 4 sterile 
polycarbonate bars to simultaneously prevent gel flotation and prevent gel contact with 
the tray bottom. Hydrogels were immersed in DMEM supplemented with 10% FBS, 100 
mU/mL penicillin, and 100 mg/L streptomycin and maintained at 37 ºC/5 % CO2.  The 
FBS lot used for the present studies contained ~50 mg/dL LDL according to 
manufacturer quality control assays. 
Hydrogel Mechanical Properties and Contraction. Following initial swelling, 
three 8 mm diameter samples were cored from each hydrogel. The thickness of each disc 
was measured using a digital caliper. These thickness measures served both as gauge 
lengths for mechanical testing as well as indicators of hydrogel degradation and/or 
SMC-mediated gel compaction with time. Following application of a 0.01 N preload, 
each hydrogel was subjected to cyclic unconstrained compression (~10% cyclic strain) at 
1 Hz using an Instron 3342. The dynamic compressive modulus of each hydrogel 
formulation was extracted from the resulting stress-strain data.  
4.2.5 Endpoint Hydrogel Analyses 
At days 14 and 35 of culture, a series of 8 mm diameter samples were collected 
from each hydrogel formulation for mechanical, biochemical, and histological analyses. 
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Mechanical samples were tested as described above.  
Collagen and Elastin Analyses. Samples harvested for biochemical analyses 
were transferred to screw-cap vials, weighed, flash-frozen in liquid nitrogen, and stored 
at -80 ºC until time of analysis. The weight of each 8 mm disc was used as a second 
indicator of gel degradation and/or compaction, since the reduction in gel volume 
associated with both of these processes would be reflected in a mass loss, assuming lack 
of commensurate neomatrix deposition (115). Hydrogel samples were digested for 72 h 
at 37 ºC in 1 ml of 0.12 M NaOH per 0.2 g hydrogel wet weight (134, 135). DNA, total 
collagen, and elastin were then analyzed per established protocols. For each assay, the 
standards used were subjected to the same association with PEGDA and GAG and to the 
same digestion conditions as the samples. Resulting collagen and elastin data were 
normalized to cell number.  
DNA Analysis. Aliquots of the hydrolyzed samples (n = 12 per formulation) 
were neutralized and their DNA content determined using the Invitrogen PicoGreen 
assay (134). DNA measures were translated to cell number using a conversion factor of 
6.6 pg DNA per cell (136). Calf thymus DNA (Sigma) served as a standard.   
Collagen Analysis. The amino acid hydroxyproline was quantified as an indirect 
measure of total collagen. In brief, aliquots (n = 4-6 per formulation) collected for 
collagen quantitation were hydrolyzed for 18 h at 110 °C in 6 M HCl. Each sample was 
then dried on a Labconco Centrivap to remove HCl, resuspended in dIH2O, and passed 
through a charcoal-packed centrifugal microcolumn (Nunc) to remove caramelized 
sugars. The resultant samples were reacted with chloramine T and p-
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dimethylbenzaldehyde reagents (134, 135). Sample absorbance was read at 550 nm 
relative to that of L-4-hydroxyproline (Sigma). Total collagen content was estimated 
from measured grams of hydroxyproline by dividing by 0.13 (137).     
Elastin Analysis. Elastin production was measured using indirect ELISA (138). 
NaOH digested samples (n = 9-14 per formulation) were neutralized and further digested 
with 0.25 M oxalic acid at 100 ºC overnight. Oxalic acid was removed from the samples 
and exchanged for PBS using Microcon YM-3 centrifugal filters (Millipore). One 
hundred μL of the resulting samples were applied to a high binding multiwell plate for 3 
h at room temperature. After blocking the plate with bovine serum albumin (BSA), 
adsorbed elastin elastin (Sigma) serving as a standard.    
 GAG Analyses. Quantification of individual GAG types as well as changes in 
the levels of specific GAG types requires specialized techniques, which generally rely on 
the identifying GAG classes based on their characteristic component disaccharides. 
Given the anticipated levels of neo-GAG synthesis (~ 5 µg/g gel = ~ 50 µg/g PEG) (116), 
the high sensitivity technique known as fluorescence assisted carbohydrate 
electrophoresis (FACE) was employed and GAG type assessments were limited to HA, 
DS, CSC-related disaccharide units.   
To isolate newly synthesized GAGs from the GAG chains which had been 
covalently linked to the PEGDA hydrogel network, a two-step degradation process was 
employed. This first phase of this process was intended to release newly deposited 
GAGs and the second step was intended to release GAGs conjugated to the hydrogel 
network. In brief, harvested hydrogel samples were sliced into a series of 30 µm sections 
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using a cryomicrotome, after which these sections were exposed to a 1 mg/mL solution 
of proteinase K (Worthington Biochemical) at 37 °C. Sectioning increased the surface 
area for enzymatic action, allowing the proteinase K to release GAGs bound to either 
proteoglycan core proteins or to cell receptors. However, since the covalent bonds 
linking the methacrylate-derivatized GAGs to the PEGDA chains are not labile by 
proteinase K, the GAGs conjugated to the hydrogel network were not released by this 
treatment. Following 24 h of digestion, the samples were heated to inactivate the 
proteinase K, after which they were centrifuged, and the supernatant collected. The gel 
sections were then rinsed with PBS, and the wash solution was combined with the initial 
proteinase K supernatant. The gels sections were then immersed in 0.1 M NaOH for 24 h 
at 37 °C to induce hydrolysis of the hydrogel structure and the release of conjugated 
GAG chains as well as of the composing PEG chains.  
Each proteinase K supernatant and NaOH treated sample was exposed to 10 
mU/µl chondroitinase ABC (Proteus vulgaris, Sigma) for 3 h at 37 ºC followed by 
exposure to 3 µL of 10 mU/µl chondroitinase ACII (Flavobacterium heparinum, 
Seikagaku America) overnight at 37 ºC (139, 140). This enzymatic treatment digested 
chains of HA, CSC and DS into their component disaccharides, which are primarily 
ΔDi-HA, ΔDi-6S, and ΔDi-4S, respectively. The chondroitinase ABC/ACII treated 
samples were then dried, fluorotagged with 2-aminoacridone HCl (Invitrogen) (140), 
and mixed with glycerol. These samples were then electrophoresed on monosaccharide 
gels prepared as previously described (140). Negative control samples of pure AMAC 
were run for each digestion condition. The gel bands were imaged using a Kodak 
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GelLogic station and analyzed using Image J software. Enzyme digestion products were 
identified by correspondence to bands in a disaccharide standard lane. The quantity of 
each disaccharide was determined from the integrated optical density of the band(s), 
internal maltriose standards, and the aliquot volume used for the enzyme digest (141). 
The measured disaccharide values were then normalized to total sample PEG content, 
which was quantified via iodine staining of the electrophoresed hydrolysis samples per 
Suggs et al (142). 
Histological Analyses. Samples harvested for histological analyses were fixed in 
10% formalin for 30 min, embedded in Tissue-Tek freezing media, and frozen at -80 oC. 
Thirty-five μm sections were cut using a cryomicrotome.  
Immunostaining. SMC ECM production and phenotype were analyzed in 
duplicate sections for each gel sample using standard immunohistochemical technique. 
All immunostaining steps took place at room temperature unless otherwise noted. 
Rehydrated sections were blocked with peroxidase for 10 min followed by 10 min 
exposure to Terminator block (Biocare Medical). Primary antibodies for elastin (BA-4, 
SCBT), collagen type I (Rockland Immunochemicals), or collagen type III (Rockland 
Immunochemicals) diluted in PBS-tween (PBS, 0.05% Tween20, 3% BSA) were then 
applied for 1 h. Primary antibodies for smooth muscle myosin heavy chain (MHC; G-4, 
SCBT), calponin h1 (CALP, SCBT), A-FABP (C-15, SCBT), and apolipoprotein B 
(apoB; ab20737, Abcam) were similarly applied to construct sections for 1 h, except that 
rehydrated sections were permeabilized with PBS-triton (PBS, 0.5% Triton X-100) for 
10 min prior to Terminator application. Bound primary antibody was detected by using 
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AP-conjugated secondary antibody (Jackson Immunochemicals) followed by application 
of the chromogen Ferangi Blue (Biocare Medical) or by using HRP-conjugated 
secondary antibody followed by application of the chromogen AEC (LabVision). Based 
on observed differences in SMC behaviors in CSC and DS gels, day 14 hydrogel 
samples were also immunostained for metabolic marker glucose 6-phosphate 
dehydrogenase (G6PD, Abcam) and ECM protein osteocalcin (SCBT) per the above 
procedure.  
Semi-Quantitative Assessments. For intracellular markers (calponin h1, MHC, 
A-FABP, apoB, and G6PD), cell counts were carried out as semi-quantitative analyses 
of immunostaining results. These counting assessments were conducted by two 
independent observers on 2-3 sections (~500-3000 SMC) from each sample according to 
established methods (143-146). For each cell, i, in a given section, a staining intensity, di, 
was recorded on a scale of 0–3, 0 = “no staining” and 3 = “highest intensity among all 
treatment groups for that antibody.” The cumulative staining intensity, d, for a given 
antibody in a particular section was calculated using the following equation: d = ( 
di)/(total cell number). In addition, since deposited ECM remained localized around the 
parent cells in each hydrogel formulation, as is characteristic for PEGDA gels (147-149), 
the relative levels of osteocalcin (day 14 samples only), collagen type I, collagen type III, 
and elastin, among hydrogel formulations were also evaluated by cell counts per the 
above procedure.  For the purposes of comparison, the resulting cumulative staining 
intensities for each formulation at a given time point were normalized to the 
corresponding HAIMW average cumulative staining intensity.  
 68
4.2.6 Statistical Analyses  
Data were reported as mean ± standard error of the mean. Comparison of sample 
means was performed by one-way ANOVA and Tukey’s post-hoc test (SPSS software), 
p < 0.05.    
 
4.3 Results 
4.3.1. Hydrogel Swelling, LDL Permissivity, and Binding Affinity 
In order to attribute differences in SMC behavior across hydrogel formulations 
specifically to initial differences in gel GAG composition, it was important that the 
remaining hydrogel material properties could be considered consistent across gels. The 
“bulk” material properties of each gel formulation were therefore characterized and 
compared. The initial water uptake, S, of each gel following polymerization was similar 
(CSC: 1.42 ± 0.02, DS: 1.38 ± 0.03, HAIMW: 1.43 ± 0.02), indicating that gel equilibrium 
hydration could be considered consistent across formulations. The ability of LDL to 
diffuse through and bind to the GAG-laden hydrogel networks was also characterized by 
exposing the swollen gels to fluorescently-labeled LDL, examining the equilibrium 
levels of LDL diffusion, and then assessing LDL retention when the external LDL 
solution was removed. Figure 16 demonstrates the ability of LDL to partition into and 
diffuse evenly throughout the GAG laden hydrogels. When the observed LDL 
fluorescence intensities within the hydrogel networks were quantified, each hydrogel 
demonstrated similar permissivity to LDL (Table 1). This result was anticipated based 
on the similarity in bulk average mesh size across hydrogel formulations, as determined 
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by the equilibrium diffusion of a set of neutral dextrans (Table 1), and based on previous 
reports indicating that the average mesh size of 10% 10kDa PEGDA hydrogels could be 
considered greater than twice the average hydrodynamic radius of LDL (150). 
Comparison of LDL retention by the GAG-containing hydrogels following the exchange 
of the external LDL solution with PBS indicated that each GAG-laden gel had a similar 
average capacity to bind LDL (Table 1).  
 
 
Figure 16. Representative side views of 3D renderings of two, representative confocal image series taken 
of PEGDA-GAG hydrogels. The upper image is of a hydrogel immersed in a fluorescently labeled LDL 
solution for 24 h prior to imaging. The external LDL solution is apparent at the upper and lower borders of 
the gel. The lower image is of a control hydrogel immersed in PBS, rather than LDL, for 24 h prior to 
imaging. The upper and lower images were generated and rendered using the same microscope and 
software settings, respectively, to ensure that the grayscale intensities of the hydrogel side-views could be 
compared. 
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4.3.2 Assessments of Alterations in GAG Levels and Gel Material Properties 
Comparison of initial and endpoint mechanical data (Table 2) suggested that 
average gel modulus could be considered indistinguishable across formulations at each 
time point. Similarly, the initial and endpoint gel thickness and mass data corresponded 
to a negligible reduction in gel volume with time (Table 2). FACE analysis of the GAGs 
within hydrolyzed day 0 gels indicated ~100% conjugation of methacrylate-derivatized 
GAG to the hydrogel networks at the time of polymerization (~11 mg GAG/g PEG = ~ 
1.1 mg/mL precursor solution = 0.79 mg/g swollen gel, Table 3). Furthermore, the 
levels of GAGs conjugated to the gel networks at day 14 were not substantially altered 
from day 0 values. Although the levels of network-conjugated GAGs at day 35 appeared 
to be decreased relative to time 0 values, these differences were not statistically 
significant (Table 3) due the variation inherent in the FACE and iodine-PEG 
quantification processes. Cumulatively, the bulk modulus, thickness, gel mass, and 
conjugated-GAG assessments indicated that the PEGDA-GAG gels retained the slow 
degradation rate and resistance to cell-mediated contraction characteristic of pure 
PEGDA hydrogels (134, 148, 151, 152).  
 
Table 1. Hydrogel Relative Mesh Size, LDL Permissivity, and LDL Retention 
Gel 
Type Relative Mesh Size LDL Diffusion into Network (µg/g)
LDL 
Retained (µg/g) 
CSC 1.01 ± 0.01 7.52 ± 0.20 0.052 ± 0.028 
DS 1.02 ± 0.01 7.37 ± 0.40 0.043 ± 0.013 
HAIMW 1.00 ± 0.01 7.52 ± 0.16 0.046 ± 0.019 
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To assess potential alterations in the GAG types experienced by encapsulated 
cells due to newly synthesized GAGs, FACE analyses were applied to GAGs released 
from thin hydrogel sections via exposure to proteinase K. These newly synthesized 
GAGs were primarily comprised of ΔDi-6S disaccharides (a primary component of CSC; 
data not shown) in each hydrogel type, and measured between 0.012-0.052 mg/g PEG, 
which is equivalent to ~0.0008-0.0038 mg GAG/g swollen gel (Table 3). In contrast to 
collagen and elastin, newly synthesized proteoglycans and GAGs are often able to 
diffuse away from the pericellular space in PEG hydrogels of similar composition to the 
ones employed herein (116, 148). Therefore, the levels of produced GAGs surrounding 
cells can be assumed to be significantly lower than the levels of GAGs conjugated to the 
hydrogel networks. 
 
Table 2. Hydrogel Modulus, Thickness, and Mass Assessments 
Modulus (kPa) Thickness (mm) Mass of 8 mm Discs (mg)Gel 
Type initial final initial final initial final 
CSC 81.6 ± 3.4 86.6 ± 1.7 0.56 ± 0.01 0.59 ± 0.01 28.4 ± 0.3 29.4 ± 0.3 
DS 79.1 ± 2.3 83.0 ± 12.2 0.55 ± 0.01 0.55 ± 0.01 27.6 ± 0.5 27.8 ± 0.4 
HAIMW 80.4 ± 3.6 81.5 ± 12.0 0.57 ± 0.01 0.56 ± 0.01 28.7 ± 0.4 28.1 ± 0.5 
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Table 3. Results from FACE-based GAG Analyses 
 
 
4.3.3 SMC Collagen and Elastin Deposition   
To gauge the extent to which encapsulated SMCs were taking on a synthetic 
phenotype, elastin and collagen production were analyzed biochemically and 
histologically at days 14 and 35. As expected for PEGDA gels (147), staining for elastin 
and individual collagen types was confined to the immediate pericellular space in each 
formulation (Figure 17), enabling reliable semi-quantitative histological analyses of 
these ECM proteins. Day 14 histological and biochemical data suggested that DS may 
enhance elastin production relative to HAIMW and CSC (Figure 18A). However, for both 
assessment methods, no statistical differences between elastin levels among hydrogel 
types were observed. In contrast, day 14 hydroxyproline measures indicated that total 
collagen levels were significantly higher in DS gels relative to HAIMW gels (p = 0.014, 
Figure 18B). Analysis of individual collagen types demonstrated that collagen type I 
deposition was significantly greater in DS gels than in CSC gels (p = 0.036), whereas 
collagen type III was significantly greater in HAIMW gels relative to both CSC (p = 0.001) 
and DS hydrogels (p = 0.008; Figure 18B). Comparison of the collagen type I and type 
GAG Source Gel Type Initial  (mg/g PEG)
Day 14  
(mg/g PEG) 
Day 35  
(mg/g PEG) 
Conjugated CSC, DS,  HAIMW 11.7  ± 3.0 10.7 ± 3.6 7.0 ± 1.2 
CSC  0.015 ± 0.003 0.012 ± 0.008 
DS  0.051 ± 0.023 0.018 ± 0.006 Synthesized 
HAIMW  0.052 ± 0.027 0.013 ± 0.006 
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III trends with that of total collagen suggested that collagen type I was the dominant 
collagen being produced by the encapsulated SMCs. By day 35, differences in elastin 
production among formulations were no longer apparent (Figure 18C), although the day 
14 trends in total collagen and collagen type I were maintained at this time-point (Figure 
18D). In particular, collagen type I deposition at day 35 was greater in DS gels than 
HAIMW gels (p = 0.050).  As shown in the notations associated with Figure 18, total 
collagen and total elastin levels per cell remained essentially unaltered from day 14 to 
day 35, indicating that that the cells had reached a steady-state between the production 
and degradation of these molecules by day 14. 
 
 
Figure 17. Representative images of day 14 CSC, DS, and HAIMW hydrogel sections immunostained for 
elastin and A-FABP. The scale bar in the upper-left image represents 40 µm and applies to all images.      
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Figure 18. ECM deposition across formulations. (A, C) Relative elastin production by both biochemical 
and histological assessments at day 14 and day 35, respectively; (B, D) relative total collagen, collagen 
type I and collagen type III production at day 14 and day 35, respectively. *, significantly different from 
CSC hydrogels, p < 0.05. #, significantly different from DS hydrogels, p < 0.05.  CSC and DS data at each 
time point has been normalized to the corresponding HAIMW data, the average values for which are noted 
above the HAIMW formulation where applicable.  For the elastin and collagen biochemical data, the units of 
the noted values are in micrograms per cell. The noted values for the immunostaining assessments are 
unitless, but represent both average intensity (on a scale of 1-3) as well as the cell fraction positively 
stained. 
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4.3.4 SMC Phenotype 
SMC acquisition of adipocyte-like or macrophage-like characteristics was 
similarly examined (Figure 19). At day 14, SMC uptake of LDL (as evidenced by 
intracellular apoB) was higher in DS gels relative to HAIMW gels (p = 0.026; Figure 
19A). In addition, expression of late-term adipogenic marker A-FABP was significantly 
greater in CSC (p = 0.034) and DS gels (p = 0.018) than in HAIMW gels (Figures 17 and 
19A). By day 35, apoB uptake was greater, not only in DS gels relative to HAIMW gels (p 
= 0.028), but also in CSC gels relative to HAIMW gels (p = 0.011). In contrast, only DS 
gels maintained increased A-FABP expression relative to HALMW gels at day 35 (p < 
0.001; Figure 19C).  
The degree to which encapsulated cells displayed markers associated with a 
mature, contractile SMC phenotype was also investigated through analysis of calponin 
h1 and MHC expression. At day 14, calponin h1 levels were greater in DS gels relative 
to both CSC (p = 0.021) and HAIMW (p = 0.011) constructs (Figures 19B). In contrast, 
MHC measures indicated that both DS (p = 0.011) and HAIMW (p = 0.039) supported 
more contractile phenotypes than CSC. By day 35, calponin h1 expression had leveled 
out among formulations, and MHC trends had shifted, with HAIMW gels supporting 
greater MHC expression than either DS (p = 0.050) or CSC (p = 0.048) gels (Figure 
19D).  
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Figure 19. Evaluation of SMC foam cell versus contractile phenotypes. (A, C) Relative apoB uptake and 
A-FABP expression at day 14 and day 35, respectively. (B, D) Relative expression of markers of a SMC 
contractile apparatus at day 14 and day 35, respectively. *, significantly different from CSC hydrogels, p < 
0.05. #, significantly different from DS hydrogels, p < 0.05.  CSC and DS data at each time point has been 
normalized to the corresponding HAIMW data, the average values for which are noted above the HAIMW 
formulation where applicable. The noted values for the immunostaining assessments are unitless but 
represent both average intensity (on a scale of 1-3) as well as the cell fraction positively stained. 
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Due to the observed differences between the apoB and A-FABP profiles of CSC 
and DS gels, day 14 hydrogel samples were also immunostained for G6PD and 
osteocalcin in order to gain further insight into the cell responses within these gels. 
G6PD is a key metabolic enzyme associated with a primarily anabolic pathway essential 
in the regulation of oxidative stress (153, 154), one of the stressors in atherosclerosis. In 
addition, osteocalcin is an ECM protein produced by foam cells in calcific plaques. As 
shown in Figure 20, both G6PD and osteocalcin were elevated in DS gels relative to 
remaining hydrogel formulations (p < 0.05). 
 
Figure 20. Relative G6PD and osteocalcin expression at day 14. *, significantly different from CSC 
hydrogels, p < 0.05. #, significantly different from DS hydrogels, p < 0.05.   
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4.4 Discussion 
The aim of the present study was to examine the impact of GAG type on SMC 
acquisition of adipocyte-like or macrophage-like characteristics within an environment 
mimetic of early atherosclerosis. The results from the aforementioned apoB and A-
FABP analyses suggest that SMCs in both CSC and DS gels were driven to take on more 
a macrophage-like phenotype than SMCs in HAIMW gels. However, only cells in DS gels 
displayed a higher expression of adipocyte marker A-FABP relative to cells in HAIMW 
gels at both days 14 and 35. Combined, these results indicate that both CSC and DS 
support greater foam cell formation than HAIMW. However, the mechanisms by which 
they induce this phenotype transition may be distinct, a possibility supported by the day 
14 G6PD and osteocalcin data. 
To assess the extent to which SMC acquisition of foam cell characteristics was 
correlated with a transition toward a synthetic phenotype, SMC collagen and elastin 
production was evaluated. No consistent differences in SMC elastin deposition were 
observed over the course of the present study. This result is in agreement with the 
literature, which indicates that, although changes in elastin levels are at times observed 
in atherosclerotic lesions, these alterations are generally not consistent in their 
directionality (155). Instead, changes in elastic fiber structure characterize 
atherosclerotic vessels (155). Regarding collagen, DS gels displayed greater deposition 
of collagen type I than CSC and HAIMW gels at both day 14 and day 35. The literature 
indicates that SMC synthesis of total collagen in general, and of collagen type I in 
particular, is upregulated in early atherosclerotic lesions (104, 156, 157). Cumulatively, 
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the present ECM data suggest that DS induces a more synthetic SMC phenotype than 
CSC or HAIMW, in agreement with the increased foam cell transition observed for DS 
relative to HAIMW. 
The increase in SMC acquisition of a synthetic phenotype in DS gels and of a 
foam cell phenotype in both CSC and DS gels was not, at least initially, marked by a 
corresponding decrease in SMC contractile marker expression. Although day 14 data 
indicated decreased MHC expression in CSC gels relative to HAIMW gels, no decrease 
was observed in SMC calponin h1 expression between CSC and HAIMW gels at this 
time-point. Furthermore, day 14 calponin h1 levels were greater in DS gels relative 
HAIMW gels. Only day 35 MHC measures suggested that the increased foam cell 
phenotype associated with SMCs in DS gels was being mirrored in the decreased 
expression of a contractile phenotype. An increase in SMC contractile marker expression 
in early atherogenesis followed by a down-regulation of these markers in later 
atherosclerotic stages has previously been documented. For instance, a recent study of 
SMCs in the aortic arch of LDL-receptor knockout mice revealed increased MHC 
expression in high cholesterol mice by day 28, coincident with the SMC proliferation 
and ECM remodeling associated with early atherosclerosis (158). However, by day 98, 
SMC MHC expression in the advancing atherosclerotic lesions had decreased (158). 
Combined, the present foam cell, synthetic, and contractile phenotype characterization 
results indicate that CSC and DS may be involved in the SMC phenotypic modulation 
associated with atherosclerosis (159). 
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The apparent link between CSC and DS and SMC foam cell formation suggested 
by the present results is in agreement with current literature. Specifically, both versican 
(a proteoglycan which bears primarily CSC and CSA side chains), and biglycan (CS/DS-
containing small leucine-rich proteoglycan) have been the focus of several recent studies 
of proteoglycan involvement in early atherosclerotic lipid deposition (10, 99, 103, 160-
162). However, the above comparisons with in vivo data must be interpreted with 
caution due to the simplified in vitro system used herein. 
Several limitations of the present manuscript merit comment. Although we 
mimicked the cell morphology and limited intercellular junctions associated with SMCs 
within atherosclerotic lesions, we did not reproduce several other aspects of early 
atherogenesis. Specifically, the proliferation and migration associated with SMC 
response to arterial wall injury were not mirrored. Indeed, SMC proliferation and 
migration were essentially prevented by same PEGDA hydrogel properties which 
permitted us to induce rounded/stellate SMC phenotypes. Furthermore, the origins of 
SMC rounding in atherosclerotic environments, which are linked to changes in ECM 
composition as well as SMC integrin profiles, were not recapitulated (118). The present 
work also did not fully replicate the complex cascade of events/interactions between 
several cell types, growth factors, cytokines, and ECM molecules which ultimately lead 
to the formation of atheromatous plaques (102, 163). Similarly, the role of the PG core 
protein in modulating SMC response to CSC or DS signals was not accounted for. 
Finally, as previously discussed, the interaction of LDL with GAG chains is ionic 
in nature (161). Thus, GAG chain length and charge densities are determining factors in 
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the levels of lipid binding per chain (161, 162). Although we have attempted to mimic 
the GAG chain lengths associated with atherosclerotic vessels in the present work, the 
CSC and DS chains conjugated to the hydrogel networks may not have charge densities 
appropriate to the atherogenic environment (164). That being said, we have reported the 
sulfur levels within the DS and CSC chains employed herein, which should allow 
appropriate comparison with future work.   
Combined, the present results supported the hypothesis that specific GAG types 
have differential influence on SMC foam cell formation. Specifically, both CSC and DS 
were associated with greater phagocytosis of apoB relative to HAIMW, although only DS 
led to sustained increases in A-FABP expression. In DS gels, increased SMC acquisition 
of foam cell phenotypes was correlated with an increased synthetic phenotype as well as 
in initial increase in the expression of contractile marker calponin h1. However, over the 
longer term, SMC expression of contractile markers in both CSC and DS gels decreased 
relative to that in HAIMW gels. The present model system can be expanded to probe the 
impact of a range of atherogenic stimuli on SMC phenotype, potentially leading to more 
effective treatments for atherosclerosis.  
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CHAPTER V 
CONCLUSIONS AND FUTURE WORK 
 
In this project, we first demonstrated that a multi-component scaffold comprised 
of polyurethane electrospun mesh layers (intended to be mimetic of arterial collagen 
fiber loading) bonded together by a fibrin hydrogel matrix (intended to be mimetic of 
arterial elastic fiber response) results in a composite construct which retains the high 
tensile strength and suture retention strength of electrospun mesh but which displays a 
“J-shaped” mechanical response similar to that of native coronary artery. To better our 
design in the future, material properties tuning of the polyurethane-based elastomers can 
be exploited to identify formulation that show desired mechanical properties and optimal 
degradation rates. Furthermore, optimization of the fibrin gel composition and composite 
construct fabrication protocol will also be focused on to improve the layer-layer 
cohesion. 
In order to create functional tissue engineered vascular grafts, well organized 
mature SMCs are required. The study of cell-material interactions can give the insight on 
designing appropriate biomaterials to regulate smooth muscle phenotype. In order to 
remove the biochemical signal from fibrin, we decided to choose inert hydrogel system, 
such as PEGDA. By using PEGDA hydrogel system, we incorporated ECM proteins, 
such as fibronectin, fibrinogen, laminin, and collagen type IV into the scaffolds in a 
more controlled manner. After 7 days of culture without additional growth factors, the 
relative expression of differentiation markers, activation of cell signaling switches, and 
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the adhesion receptor integrin profile of smooth muscle precursor 10T½ cells were 
carefully examined. Surprisingly to us, no significant difference was detected in all the 
three aspects. It suggests that ECM protein identity is a weak variable in driving 
progenitor cell differentiation at least at the concentration studied. 
To further study the cell-material interactions, we chose another family of ECM 
componets, glycosaminoglycans (GAGs). Cumulatively, the present results supported 
the hypothesis that specific GAG types have differential influence on SMC foam cell 
formation. Both CSC and DS showed higher apoB uptake relative to HAIMW, although 
only DS had sustained elevation in A-FABP expression. The increased SMC acquisition 
of a foam cell phenotype in DS gels was associated with an increased synthetic 
phenotype and a decreased expression of contractile marker MHC as well at day 35. 
Increases in the amount of externally applied LDL, which was maintained at relatively 
low levels in the current work, would be expected to enhance observed differences 
among hydrogel formulations.  
From all the previous literature, a lot of ECM properties other than the ECM 
identity can also be important in determining the cell fates of progenitor cells, such as 
ECM geometry/topography (57), ECM stiffness (54), control of cell morphology (165) 
and etc. For instance, impact of cell orientation on cellular behavior can be studied using 
transparency-based photolithographic patterning method described previously (166, 167). 
The RGDS patterns and cell patterns are shown in Figure 21, four different masks, 
namely, stripes, checkers, loops, half loops, were used here to assess the impact of 
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different cell orientations. As shown in Figure 21, cells in stripe pattern showed much 
better alignment than checkers and others. 
 
 
Figure 21. RGDS patterning on PEGDA hydrogel (left panel) and cell patterning on top of the RGDS 
patterning (right panel). 
 
In order to improve our design of biomaterials and tissue engineered grafts, a 
better understanding of cell material interactions would never be overemphasized. In the 
future, study of cell material interactions from other aspects, mainly on cell orientation 
and cell morphology would be performed to give more insight into tissue engineering 
applications.  
 85
REFERENCES 
 
1. Ratcliffe, A. Tissue engineering of vascular grafts. Matrix Biol. 19(4): 353-357. 
2000. 
 
2. Tu, J.V., Pashos, C.L., Naylor, C.D., Chen, E.L., Normand, S.L., Newhouse, 
J.P., McNeil, B.J. Use of cardiac procedures and outcomes in elderly patients 
with myocardial infarction in the United States and Canada. New England 
Journal of Medicine. 336(21): 1500-1505. 1997. 
 
3. Lloyd-Jones. Heart disease and stroke statistics-2009 update: a report from the 
American Heart Association Statistics Committee and Stroke Statistics 
Subcommittee. Circulation. 119(3): 480-486. 2009. 
 
4. McKee, J.A., Banik, S.S., Boyer, M.J., Hamad, N.M., Lawson, J.H., Niklason, 
L.E., Counter, C.M. Human arteries engineered in vitro. EMBO Reports. 4(6): 
633-638. 2003. 
 
5. Nerem, R.M., Seliktar, D. Vascular tissue engineering. Annual Review of 
Biomedical Engineering. 3: 225-243. 2001. 
 
6. Hahn, M.S., McHale, M.K., Wang, E., Schmedlen, R.H., West, J.L. 
Physiologic pulsatile flow bioreactor conditioning of poly(ethylene glycol)-
based tissue engineered vascular grafts. Annals of Biomedical Engineering. 
35(2): 190-200. 2007. 
 
7. Lafleur, M.A., Handsley, M.M., Edwards, D.R. Metalloproteinases and their 
inhibitors in angiogenesis. Expert Reviews in Molecular Medicine. 5(23): 1-39. 
2003. 
 
8. Langer, R., Vacanti, J.P. Tissue engineering. Science. 260(5110): 920-926. 
1993. 
 
9. Griffith, L.G., Naughton, G. Tissue engineering - current challenges and 
expanding opportunities. Science. 295(5557): 1009-1014. 2002. 
 
10. Nakashima, Y., Wight, T.N., Sueishi, K. Early atherosclerosis in humans: role 
of diffuse intimal thickening and extracellular matrix proteoglycans. 
Cardiovasc. Res. 79(1): 14-23. 2008. 
 
11. John, L.C. Biomechanics of coronary artery and bypass graft disease: potential 
new approaches. The Annals of Thoracic Surgery. 87(1): 331-338. 2009. 
 
 86
12. van Andel, C.J., Pistecky, P.V., Borst, C. Mechanical properties of porcine and 
human arteries: implications for coronary anastomotic connectors. The Annals 
of Thoracic Surgery. 76(1): 58-64. 2003. 
 
13. Roach, M.R., Burton, A.C. The reason for the shape of the distensibility curves 
of arteries. Canadian Journal of Biochemistry and Physiology. 35(8): 681-690. 
1957. 
 
14. Seliktar, D., Black, R.A., Vito, R.P., Nerem, R.M. Dynamic mechanical 
conditioning of collagen-gel blood vessel constructs induces remodeling in 
vitro. Annals of Biomedical Engineering. 28(4): 351-362. 2000. 
15. Isenberg, B.C., Tranquillo, R.T. Long-term cyclic distention enhances the 
mechanical properties of collagen-based media-equivalents. Annals of 
Biomedical Engineering. 31(8): 937-949. 2003. 
 
16. Solan, A., Mitchell, S., Moses, M., Niklason, L. Effect of pulse rate on collagen 
deposition in the tissue-engineered blood vessel. Tissue Engineering. 9(4): 579-
586. 2003. 
 
17. Ma, Z.W., Kotaki, M., Inai, R., Ramakrishna, S. Potential of nanofiber matrix 
as tissue-engineering scaffolds. Tissue Engineering. 11(1-2): 101-109. 2005. 
 
18. Bashur, C.A., Dahlgren, L.A., Goldstein, A.S. Effect of fiber diameter and 
orientation on fibroblast morphology and proliferation on electrospun 
poly(D,L-lactic-co-glycolic acid) meshes. Biomaterials. 27(33): 5681-5688. 
2006. 
 
19. Guelcher, S.A. Biodegradable polyurethanes: synthesis and applications in 
regenerative medicine. Tissue Engineering Part B Review. 14(1): 3-17. 2008. 
 
20. Guelcher, S.A., Srinivasan, A., Dumas, J.E., Didier, J.E., McBride, S., 
Hollinger, J.O. Synthesis, mechanical properties, biocompatibility, and 
biodegradation of polyurethane networks from lysine polyisocyanates. 
Biomaterials. 29(12): 1762-1775. 2008. 
 
21. Guelcher, S.A., Gallagher, K.M., Didier, J.E., Klinedinst, D.B., Doctor, J.S., 
Goldstein, A.S., Wilkes, G.L., Beckman, E.J., Hollinger, J.O. Synthesis of 
biocompatible segmented polyurethanes from aliphatic diisocyanates and 
diurea diol chain extenders. Acta biomaterialia. 1(4): 471-484. 2005. 
 
22. Kavlock, K.D., Pechar, T.W., Hollinger, J.O., Guelcher, S.A., Goldstein, A.S. 
Synthesis and characterization of segmented poly(esterurethane urea) 
elastomers for bone tissue engineering. Acta Biomaterialia. 3(4): 475-484. 
2007. 
 87
 
23. Soletti, L., Hong, Y., Guan, J., Stankus, J.J., El-Kurdi, M.S., Wagner, W.R., 
Vorp, D.A. A bilayered elastomeric scaffold for tissue engineering of small 
diameter vascular grafts. Acta Biomaterialia. 6(1): 110-122. 2010. 
 
24. Stylianopoulos, T., Bashur, C.A., Goldstein, A.S., Guelcher, S.A., Barocas, 
V.H. Computational predictions of the tensile properties of electrospun fibre 
meshes: effect of fibre diameter and fibre orientation. Journal of the 
Mechanical Behavior of Biomedical Materials. 1(4): 326-335. 2008. 
 
25. Drury, J.L., Mooney, D.J. Hydrogels for tissue engineering: scaffold design 
variables and applications. Biomaterials. 24(24): 4337-4351. 2003. 
 
26. Spotnitz, W.D. Fibrin sealant: past, present, and future: a brief review. World 
Journal of Surgery. 34(4): 632-634. 2010. 
 
27. Ahmann, K.A., Weinbaum, J.S., Johnson, S.L., Tranquillo, R.T. Fibrin 
degradation enhances vascular smooth muscle cell proliferation and matrix 
deposition in fibrin-based tissue constructs fabricated in vitro. Tissue 
Engineering Part A. 16(10): 3261-3270. 2010. 
 
28. Huynh, T.N., Tranquillo, R.T. Fusion of concentrically layered tubular tissue 
constructs increases burst strength. Annals of Biomedical Engineering. 38(6): 
2226-2236. 2010. 
 
29. Long, J.L., Tranquillo, R.T. Elastic fiber production in cardiovascular tissue-
equivalents. Matrix Biol. 22(4): 339-350. 2003. 
 
30. Tranquillo, R.T., Girton, T.S., Bromberek, B.A., Triebes, T.G., Mooradian, D.L. 
Magnetically orientated tissue-equivalent tubes: application to a 
circumferentially orientated media-equivalent. Biomaterials. 17(3): 349-357. 
1996. 
 
31. Liu, H., Collins, S.F., Suggs, L.J. Three-dimensional culture for expansion and 
differentiation of mouse embryonic stem cells. Biomaterials. 27(36): 6004-
6014. 2006. 
 
32. Zhang, G., Wang, X.H., Wang, Z.L., Zhang, J.Y., Suggs, L. A PEGylated fibrin 
patch for mesenchymal stem cell delivery. Tissue Engineering. 12(1): 9-19. 
2006. 
 
33. Munoz-Pinto, D.J., Jimenez-Vergara, A.C., Gelves, L.M., McMahon, R.E., 
Guiza-Arguello, V., Hahn, M.S. Probing vocal fold fibroblast response to 
 88
hyaluronan in 3D contexts. Biotechnology and Bioengineering. 104(4): 821-
831. 2009. 
 
34. Bashur, C.A., Shaffer, R.D., Dahlgren, L.A., Guelcher, S.A., Goldstein, A.S. 
Effect of fiber diameter and alignment of electrospun polyurethane meshes on 
mesenchymal progenitor cells. Tissue Engineering. 15(9): 2435-2445. 2009. 
 
35. Johnson, C.P., How, T., Scraggs, M., West, C.R., Burns, J. A biomechanical 
study of the human vertebral artery with implications for fatal arterial injury. 
Forensic Science International 109(3): 169-182. 2000. 
 
36. Bulick, A.S., Munoz-Pinto, D.J., Qu, X., Mani, M., Cristancho, D., Urban, M., 
Hahn, M.S. Impact of endothelial cells and mechanical conditioning on smooth 
muscle cell extracellular matrix production and differentiation. Tissue 
Engineering Part A. 15(4): 815-825. 2009. 
 
37. Hirschi, K.K., Lai, L., Belaguli, N.S., Dean, D.A., Schwartz, R.J., Zimmer, 
W.E. Transforming growth factor-beta induction of smooth muscle cell 
phenotype requires transcriptional and post-transcriptional control of serum 
response factor. The Journal of Biological Chemistry. 277(8): 6287-6295. 2002. 
 
38. Hirschi, K.K., Rohovsky, S.A., D'Amore, P.A. PDGF, TGF-beta, and 
heterotypic cell-cell interactions mediate endothelial cell-induced recruitment 
of 10T1/2 cells and their differentiation to a smooth muscle fate. The Journal of 
Cell Biology. 141(3): 805-814. 1998. 
 
39. Syedain, Z.H., Weinberg, J.S., Tranquillo, R.T. Cyclic distension of fibrin-
based tissue constructs: evidence of adaptation during growth of engineered 
connective tissue. Proc. Natl. Acad. Sci. U. S. A. 105(18): 6537-6542. 2008. 
 
40. Posey, J., Geddes, L. Measurement of the modulus of elasticity of the arterial 
wall. Cardiovasc. Res. Ctr. Bull. 111(4): 83-103. 1973. 
 
41. Bryant, S.J., Nuttelman, C.R., Anseth, K.S. Cytocompatibility of UV and 
visible light photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro. 
Journal of Biomaterials Science. 11(5): 439-457. 2000. 
 
42. Lu, X., Pandit, A., Kassab, G.S. Biaxial incremental homeostatic elastic moduli 
of coronary artery: two-layer model. American Journal of Physiology. 287(4): 
H1663-1669. 2004. 
 
43. Weinberg, C.B., Bell, E. A blood vessel model constructed from collagen and 
cultured vascular cells. Science. 231(4736): 397-400. 1986. 
 
 89
44. Chesler, N.C., Ku, D.N., Galis, Z.S. Transmural pressure induces matrix-
degrading activity in porcine arteries ex vivo. The American Journal of 
Physiology. 277(5): H2002-2009. 1999. 
 
45. Hasaneen, N.A., Zucker, S., Cao, J., Chiarelli, C., Panettieri, R.A., Foda, H.D. 
Cyclic mechanical strain-induced proliferation and migration of human airway 
smooth muscle cells: role of EMMPRIN and MMPs. FASEB J. 19(11): 1507-
1509. 2005. 
 
46. Mills, I., Cohen, C.R., Kamal, K., Li, G., Shin, T., Du, W., Sumpio, B.E. Strain 
activation of bovine aortic smooth muscle cell proliferation and alignment: 
study of strain dependency and the role of protein kinase A and C signaling 
pathways. Journal of Cellular Physiology. 170(3): 228-234. 1997. 
 
47. Ekaputra, A.K., Prestwich, G.D., Cool, S.M., Hutmacher, D.W. Combining 
electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional 
cellularization of hybrid constructs. Biomacromolecules. 9(8): 2097-2103. 
2008. 
 
48. Nieponice, A., Soletti, L., Guan, J., Deasy, B.M., Huard, J., Wagner, W.R., 
Vorp, D.A. Development of a tissue-engineered vascular graft combining a 
biodegradable scaffold, muscle-derived stem cells and a rotational vacuum 
seeding technique. Biomaterials. 29(7): 825-833. 2008. 
 
49. Bhatia, R., Hare, J.M. Mesenchymal stem cells: future source for reparative 
medicine. Congestive Heart Failure. 11(2): 87-91. 2005. 
 
50. Au, P., Tam, J., Fukumura, D., Jain, R.K. Bone marrow-derived mesenchymal 
stem cells facilitate engineering of long-lasting functional vasculature. Blood. 
111(9): 4551-4558. 2008. 
 
51. Narita, Y., Yamawaki, A., Kagami, H., Ueda, M., Ueda, Y. Effects of 
transforming growth factor-beta 1 and ascorbic acid on differentiation of 
human bone-marrow-derived mesenchymal stem cells into smooth muscle cell 
lineage. Cell Tissue Res. 333(3): 449-459. 2008. 
 
52. Kim, P.D., Peyton, S.R., VanStrien, A.J., Putnam, A.J. The influence of 
ascorbic acid, TGF-beta1, and cell-mediated remodeling on the bulk 
mechanical properties of 3-D PEG-fibrinogen constructs. Biomaterials. 30(23-
24): 3854-3864. 2009. 
 
53. Treguer, K., Naye, F., Thiebaud, P., Fedou, S., Soulet, F., Theze, N., Faucheux, 
C. Smooth muscle cell differentiation from human bone marrow: variations in 
 90
cell type specific markers and Id gene expression in a new model of cell culture. 
Cell Biol. Int. 33(6): 621-631. 2009. 
 
54. Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E. Matrix elasticity directs 
stem cell lineage specification. Cell. 126(4): 677-689. 2006. 
 
55. Salasznyk, R.M., Williams, W.A., Boskey, A., Batorsky, A., Plopper, G.E. 
Adhesion to vitronectin and collagen I promotes osteogenic differentiation of 
human mesenchymal stem cells. J. Biomed. Biotechnol. 2004(1): 24-34. 2004. 
 
56. Klees, R.F., Salasznyk, R.M., Kingsley, K., Williams, W.A., Boskey, A., 
Plopper, G.E. Laminin-5 induces osteogenic gene expression in human 
mesenchymal stem cells through an ERK-dependent pathway. Mol. Biol. Cell. 
16(2): 881-890. 2005. 
 
57. Guilak, F., Cohen, D.M., Estes, B.T., Gimble, J.M., Liedtke, W., Chen, C.S. 
Control of stem cell fate by physical interactions with the extracellular matrix. 
Cell Stem Cell. 5(1): 17-26. 2009. 
 
58. Hungerford, J.E., Little, C.D. Developmental biology of the vascular smooth 
muscle cell: building a multilayered vessel wall. Journal of Vascular Research. 
36(1): 2-27. 1999. 
 
59. Carmeliet, P. Angiogenesis in health and disease. Nature Medicine. 9(6): 653-
660. 2003. 
 
60. Risau, W., Lemmon, V. Changes in the vascular extracellular matrix during 
embryonic vasculogenesis and angiogenesis. Dev. Biol. 125(2): 441-450. 1988. 
 
61. George, E.L., Georges-Labouesse, E.N., Patel-King, R.S., Rayburn, H., Hynes, 
R.O. Defects in mesoderm, neural tube and vascular development in mouse 
embryos lacking fibronectin. Development. 119(4): 1079-1091. 1993. 
 
62. Drake, C.J., Davis, L.A., Walters, L., Little, C.D. Avian vasculogenesis and the 
distribution of collagens I, IV, laminin, and fibronectin in the heart primordia. 
The Journal of Experimental Zoology. 255(3): 309-322. 1990. 
 
63. Ruger, B.M., Breuss, J., Hollemann, D., Yanagida, G., Fischer, M.B., 
Mosberger, I., Chott, A., Lang, I., Davis, P.F., Hocker, P., Dettke, M. Vascular 
morphogenesis by adult bone marrow progenitor cells in three-dimensional 
fibrin matrices. Differentiation. 76(7): 772-783. 2008. 
 
64. Lien, S.C., Usami, S., Chien, S., Chiu, J.J. Phosphatidylinositol 3-kinase/Akt 
pathway is involved in transforming growth factor-beta1-induced phenotypic 
 91
modulation of 10T1/2 cells to smooth muscle cells. Cellular signalling. 18(8): 
1270-1278. 2006. 
 
65. Miller, S.A., Brown, A.J., Farach-Carson, M.C., Kirn-Safran, C.B. HIP/RPL29 
down-regulation accompanies terminal chondrocyte differentiation. 
Differentiation. 71(6): 322-336. 2003. 
 
66. Sato, M., Kawai-Kowase, K., Sato, H., Oyama, Y., Kanai, H., Ohyama, Y., 
Suga, T., Maeno, T., Aoki, Y., Tamura, J., Sakamoto, H., Nagai, R., 
Kurabayashi, M. c-Src and hydrogen peroxide mediate transforming growth 
factor-beta1-induced smooth muscle cell-gene expression in 10T1/2 cells. 
Arteriosclerosis, Thrombosis, and Vascular Biology. 25(2): 341-347. 2005. 
 
67. Wang, J., Li, A., Wang, Z., Feng, X., Olson, E.N., Schwartz, R.J. Myocardin 
sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts. 
Molecular and Cellular Biology. 27(2): 622-632. 2007. 
 
68. Pampaloni, F., Reynaud, E.G., Stelzer, E.H. The third dimension bridges the 
gap between cell culture and live tissue. Nature Reviews Molecular Cell 
Biology. 8(10): 839-845. 2007. 
 
69. Nguyen, K.T., West, J.L. Photopolymerizable hydrogels for tissue engineering 
applications. Biomaterials. 23(22): 4307-4314. 2002. 
 
70. Greenwald, R.B., Conover, C.D., Choe, Y.H. Poly(ethylene glycol) conjugated 
drugs and prodrugs: a comprehensive review. Critical Reviews in Therapeutic 
Drug Carrier Systems. 17(2): 101-161. 2000. 
 
71. Rizzi, S.C., Ehrbar, M., Halstenberg, S., Raeber, G.P., Schmoekel, H.G., 
Hagenmuller, H., Muller, R., Weber, F.E., Hubbell, J.A. Recombinant protein-
co-PEG networks as cell-adhesive and proteolytically degradable hydrogel 
matrixes. Part II: biofunctional characteristics. Biomacromolecules. 7(11): 
3019-3029. 2006. 
 
72. Lee, W.K., Ichi, T., Ooya, T., Yamamoto, T., Katoh, M., Yui, N. Novel 
poly(ethylene glycol) scaffolds crosslinked by hydrolyzable polyrotaxane for 
cartilage tissue engineering. Journal of Biomedical Materials Research. 67(4): 
1087-1092. 2003. 
 
73. Halstenberg, S., Panitch, A., Rizzi, S., Hall, H., Hubbell, J.A. Biologically 
engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and 
plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules. 
3(4): 710-723. 2002. 
 
 92
74. Lee, H.J., Lee, J.S., Chansakul, T., Yu, C., Elisseeff, J.H., Yu, S.M. Collagen 
mimetic peptide-conjugated photopolymerizable PEG hydrogel. Biomaterials. 
27(30): 5268-5276. 2006. 
 
75. Hahn, M.S., Taite, L.J., Moon, J.J., Rowland, M.C., Ruffino, K.A., West, J.L. 
Photolithographic patterning of polyethylene glycol hydrogels. Biomaterials. 
27(12): 2519-2524. 2006. 
 
76. Roberts, M.J., Bentley, M.D., Harris, J.M. Chemistry for peptide and protein 
PEGylation. Advanced Drug Delivery Reviews. 54(4): 459-476. 2002. 
 
77. Hern, D.L., Hubbell, J.A. Incorporation of adhesion peptides into nonadhesive 
hydrogels useful for tissue resurfacing. Journal of Biomedical Materials 
Research. 39(2): 266-276. 1998. 
 
78. Hummon, A.B., Lim, S.R., Difilippantonio, M.J., Ried, T. Isolation and 
solubilization of proteins after TRIzol extraction of RNA and DNA from 
patient material following prolonged storage. Biotechniques. 42(4): 467-470. 
2007. 
 
79. Wang, E.A., Israel, D.I., Kelly, S., Luxenberg, D.P. Bone morphogenetic 
protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. 
Growth Factors. 9(1): 57-71. 1993. 
 
80. Chien, C.M., Cheng, J.L., Chang, W.T., Tien, M.H., Wu, W.Y., Chang, Y.H., 
Chang, H.Y., Chen, S.T. Cell phenotype high analysis using a cell fluid-based 
microchip with sensitivity and accurate quantitation. Journal of 
Chromatography B-Analytical Technologies in the Biomedical and Life 
Sciences. 795(1): 1-8. 2003. 
 
81. Wang, M., Su, Y., Sun, H., Wang, T., Yan, G., Ran, X., Wang, F., Cheng, T., 
Zou, Z. Induced endothelial differentiation of cells from a murine embryonic 
mesenchymal cell line C3H/10T1/2 by angiogenic factors in vitro. 
Differentiation. 79(1): 21-30. 2010. 
 
82. Chamberlain, G., Wright, K., Rot, A., Ashton, B., Middleton, J. Murine 
mesenchymal stem cells exhibit a restricted repertoire of functional chemokine 
receptors: comparison with human. PloS One. 3(8): e2934. 2008. 
 
83. Ruoslahti, E. Integrins. The Journal of Clinical Investigation. 87(1): 1-5. 1991. 
 
84. Giancotti, F.G., Ruoslahti, E. Integrin signaling. Science. 285(5430): 1028-
1032. 1999. 
 
 93
85. Sobue, K., Hayashi, K., Nishida, W. Expressional regulation of smooth muscle 
cell-specific genes in association with phenotypic modulation. Molecular and 
Cellular Biochemistry. 190(1-2): 105-118. 1999. 
 
86. Chang, L., Karin, M. Mammalian MAP kinase signalling cascades. Nature. 
410(6824): 37-40. 2001. 
 
87. Chen, Q., Kinch, M.S., Lin, T.H., Burridge, K., Juliano, R.L. Integrin-mediated 
cell adhesion activates mitogen-activated protein kinases. The Journal of 
Biological Chemistry. 269(43): 26602-26605. 1994. 
 
88. Zhu, X., Assoian, R.K. Integrin-dependent activation of MAP kinase: a link to 
shape-dependent cell proliferation. Molecular Biology of the Cell. 6(3): 273-
282. 1995. 
 
89. Prusty, D., Park, B.H., Davis, K.E., Farmer, S.R. Activation of MEK/ERK 
signaling promotes adipogenesis by enhancing peroxisome proliferator-
activated receptor gamma (PPARgamma) and C/EBPalpha gene expression 
during the differentiation of 3T3-L1 preadipocytes. The Journal of Biological 
Chemistry. 277(48): 46226-46232. 2002. 
 
90. Gong, Z., Niklason, L.E. Small-diameter human vessel wall engineered from 
bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 22(6): 
1635-1648. 2008. 
 
91. Hedin, U., Bottger, B.A., Forsberg, E., Johansson, S., Thyberg, J. Diverse 
effects of fibronectin and laminin on phenotypic properties of cultured arterial 
smooth muscle cells. The Journal of Cell Biology. 107(1): 307-319. 1988. 
 
92. Tibbitt, M.W., Anseth, K.S. Hydrogels as extracellular matrix mimics for 3D 
cell culture. Biotechnology and Bioengineering. 103(4): 655-663. 2009. 
 
93. Speer, M.Y., Yang, H.Y., Brabb, T., Leaf, E., Look, A., Lin, W.L., Frutkin, A., 
Dichek, D., Giachelli, C.M. Smooth muscle cells give rise to 
osteochondrogenic precursors and chondrocytes in calcifying arteries. 
Circulation Research. 104(6): 733-741. 2009. 
 
94. Halayko, A.J., Solway, J. Molecular mechanisms of phenotypic plasticity in 
smooth muscle cells. Journal of Applied Physiology. 90(1): 358-368. 2001. 
 
95. Shanahan, C.M., Cary, N.R., Salisbury, J.R., Proudfoot, D., Weissberg, P.L., 
Edmonds, M.E. Medial localization of mineralization-regulating proteins in 
association with Monckeberg's sclerosis: evidence for smooth muscle cell-
mediated vascular calcification. Circulation. 100(21): 2168-2176. 1999. 
 94
 
96. Moe, S.M., O'Neill, K.D., Duan, D., Ahmed, S., Chen, N.X., Leapman, S.B., 
Fineberg, N., Kopecky, K. Medial artery calcification in ESRD patients is 
associated with deposition of bone matrix proteins. Kidney International. 61(2): 
638-647. 2002. 
 
97. Ross, R. Atherosclerosis--an inflammatory disease. The New England Journal 
of Medicine. 340(2): 115-126. 1999. 
 
98. Lloyd-Jones, D., Adams, R.J., Brown, T.M., Carnethon, M., Dai, S., De 
Simone, G., Ferguson, T.B., Ford, E., Furie, K., Gillespie, C., Go, A., 
Greenlund, K., Haase, N., Hailpern, S., Ho, P.M., Howard, V., Kissela, B., 
Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M.M., Meigs, 
J., Mozaffarian, D., Mussolino, M., Nichol, G., Roger, V., Rosamond, W., 
Sacco, R., Sorlie, P., Stafford, R., Thom, T., Wasserthiel-Smoller, S., Wong, 
N.D., Wylie-Rosett, J.; American Heart Association Statistics Committee and 
Stroke Statistics Subcommittee. Heart disease and stroke statistics--2010 
update: a report from the American Heart Association. Circulation. 121(7):e46-
e215. 2010. 
 
99. Nakashima, Y., Fujii, H., Sumiyoshi, S., Wight, T.N., Sueishi, K. Early human 
atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings 
followed by macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 27(5): 
1159-1165. 2007. 
 
100. Khalil, M.F., Wagner, W.D., Goldberg, I.J. Molecular interactions leading to 
lipoprotein retention and the initiation of atherosclerosis. Arterioscler. Thromb. 
Vasc. Biol. 24(12): 2211-2218. 2004. 
 
101. Williams, K.J., Tabas, I. The response-to-retention hypothesis of early 
atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15(5): 551-561. 1995. 
 
102. Camejo, G., Hurt-Camejo, E., Wiklund, O., Bondjers, G. Association of apo B 
lipoproteins with arterial proteoglycans: pathological significance and 
molecular basis. Atherosclerosis. 139(2): 205-222. 1998. 
 
103. Vijayagopal, P., Menon, P.V. Varied low density lipoprotein binding property 
of proteoglycans synthesized by vascular smooth muscle cells cultured on 
extracellular matrix. Atherosclerosis. 178(1): 75-82. 2005. 
 
104. Katsuda, S., Boyd, H.C., Fligner, C., Ross, R., Gown, A.M. Human 
atherosclerosis. III. Immunocytochemical analysis of the cell composition of 
lesions of young adults. Am. J. Pathol. 140(4): 907-914. 1992. 
 
 95
105. Davies, J.D., Carpenter, K.L.H., Challis, I.R., Figg, N.L., McNair, R., 
Proudfoot, D., Weissberg, P.L., Shanahan, C.M. Adipocytic differentiation and 
liver X receptor pathways regulate the accumulation of triacylglycerols in 
human vascular smooth muscle cells. J. Biol. Chem. 280(5): 3911-3919. 2005. 
 
106. Rong, J.X., Shapiro, M., Trogan, E., Fisher, E.A. Transdifferentiation of mouse 
aortic smooth muscle cells to a macrophage-like state after cholesterol loading. 
Proc. Natl. Acad. Sci. U. S. A. 100(23): 13531-13536. 2003. 
 
107. Wada, Y., Sugiyama, A., Yamamoto, T., Naito, M., Noguchi, N., Yokoyama, 
S., Tsujita, M., Kawabe, Y., Kobayashi, M., Izumi, A., Kohro, T., Tanaka, T., 
Taniguchi, H., Koyama, H., Hirano, K., Yamashita, S., Matsuzawa, Y., Niki, E., 
Hamakubo, T., Kodama, T. Lipid accumulation in smooth muscle cells under 
LDL loading is independent of LDL receptor pathway and enhanced by 
hypoxic conditions. Arterioscler. Thromb. Vasc. Biol. 22(10): 1712-1719. 2002. 
 
108. Papakonstantinou, E., Karakiulakis, G., Eickelberg, O., Perruchoud, A., Block, 
L., Roth, M. A 340 kDa hyaluronic acid secreted by human vascular smooth 
muscle cells regulates their proliferation and migration. Glycobiology. 8(8): 
821-830. 1998. 
 
109. Stevens, R.L., Colombo, M., Gonzales, J.J., Hollander, W., Schmid, K. The 
glycosaminoglycans of the human artery and their changes in atherosclerosis. J. 
Clin. Invest. 58(2): 470-481. 1976. 
 
110. Wagner, W.D. Proteoglycan Structure and Function as Related to 
Atherosclerosis. Annals of the New York Academy of Sciences. 454: 52-68. 
1985. 
 
111. Tammi, M., Seppälä, P.O., Lehtonen, A., Möttönen, M. Connective tissue 
components in normal and atherosclerotic human coronary arteries. 
Atherosclerosis 29(2): 191-194. 1978. 
 
112. Theocharis, A.D., Theocharis, D.A., De Luca, G., Hjerpe, A., Karamanos, N.K. 
Compositional and structural alterations of chondroitin and dermatan sulfates 
during the progression of atherosclerosis and aneurysmal dilatation of the 
human abdominal aorta. Biochimie. 84(7): 667-674. 2002. 
 
113. Papakonstantinou, E., Roth, M., Block, L.H., Mirtsou-Fidani, V., Argiriadis, P., 
Karakiulakis, G. The differential distribution of hyaluronic acid in the layers of 
human atheromatic aortas is associated with vascular smooth muscle cell 
proliferation and migration. Atherosclerosis. 138(1): 79-89. 1998. 
 
 96
114. Gombotz, W.R., Wang, G.H., Horbett, T.A., Hoffman, A.S. Protein adsorption 
to poly(ethylene oxide) surfaces. J. Biomed. Mater. Res. 25(12): 1547-1562. 
1991. 
 
115. Munoz-Pinto, D.J., Jimenez-Vergara, A.C., Gelves, L.M., McMahon, R.E., 
Guiza-Arguello, V., Hahn, M.S. Probing vocal fold fibroblast response to 
hyaluronan in 3D contexts. Biotechnology and Bioengineering. 104(4): 821-
831. 2009. 
 
116. Munoz-Pinto, D.J., Bulick, A.S., Hahn, M.S. Uncoupled investigation of 
scaffold modulus and mesh size on smooth muscle cell behavior. J. Biomed. 
Mater. Res. Part A. 90(1): 303-316. 2009. 
 
117. Glukhova, M., Frid, M., Koteliansky, V. Phenotypic changes of human aortic 
smooth muscle cells during development and in the adult vessel. Am. J. Physiol. 
261(4): 78-80. 1991. 
 
118. Raines, E.W., Ross, R. Smooth muscle cells and the pathogenesis of the lesions 
of atherosclerosis. British Heart Journal. 69(1): S30-37. 1993. 
 
119. Orlandi, A., Bochaton-Piallat, M.-L., Gabbiani, G., Spagnoli, L.G. Aging, 
smooth muscle cells and vascular pathobiology: implications for 
atherosclerosis. Atherosclerosis. 188(2): 221-230. 2006. 
 
120. Bobryshev, Y.V., Lord, R.S.A. Langhans cells of human arterial intima: 
uniform by stellate appearance but different by nature. Tissue and Cell. 28(2): 
177-194. 1996. 
 
121. Kruse, R., Merten, M., Buddecke, E., Schmidt, A., Völker, W., Yoshida, K. 
Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta. 
Basic Research in Cardiology. 91(5): 344-352. 1996. 
 
122. Hasegawa, H., Kanai, H., Koiwa, Y., Ichiki, M., Tezuka, F. Measurement of 
elastic moduli of tissue components in atherosclerotic plaques by ultrasonic 
phased tracking method.  Ultrasonics Symposium, 2002. Proceedings. 2002 
IEEE, 2: 1847-1850. 2002, 
 
123. Bulick, A.S., Muñoz-Pinto, D.J., Qu, X., Mani, M., Cristancho, D., Urban, M., 
Hahn, M.S. Impact of endothelial cells and mechanical conditioning on smooth 
muscle cell extracellular matrix production and differentiation. Tissue 
Engineering Part A. 15(4): 815-825. 2009. 
 
 97
124. Masters, K.S., Shah, D.N., Leinwand, L.A., Anseth, K.S. Crosslinked 
hyaluronan scaffolds as a biologically active carrier for valvular interstitial 
cells. Biomaterials. 26(15): 2517-2525. 2005. 
 
125. Bryant, S.J., Davis-Arehart, K.A., Luo, N., Shoemaker, R.K., Arthur, J.A., 
Anseth, K.S. Synthesis and characterization of photopolymerized 
multifunctional hydrogels: Water-soluble poly(vinyl alcohol) and chondroitin 
sulfate macromers for chondrocyte encapsulation. Macromolecules. 37(18): 
6726-6733. 2004. 
 
126. Masters, K.S., Shah, D.N., Walker, G., Leinwand, L.A., Anseth, K.S. 
Designing scaffolds for valvular interstitial cells: cell adhesion and function on 
naturally derived materials. J. Biomed. Mater. Res. Part A. 71(1): 172-180. 
2004. 
 
127. Benoit, D.S., Anseth, K.S. Heparin functionalized PEG gels that modulate 
protein adsorption for hMSC adhesion and differentiation. Acta Biomaterialia. 
1(4): 461-470. 2005. 
 
128. Benoit, D.S., Durney, A.R., Anseth, K.S. The effect of heparin-functionalized 
PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic 
differentiation. Biomaterials. 28(1): 66-77. 2007. 
 
129. Ford, M.C., Bertram, J.P., Hynes, S.R., Michaud, M., Li, Q., Young, M., Segal, 
S.S., Madri, J.A., Lavik, E.B. A macroporous hydrogel for the coculture of 
neural progenitor and endothelial cells to form functional vascular networks in 
vivo. Proc. Natl. Acad. Sci. U. S. A. 103(8): 2512-2517. 2006. 
 
130. Watkins, A.W., Anseth, K.S. Investigation of molecular transport and 
distributions in poly(ethylene glycol) hydrogels with confocal laser scanning 
microscopy. Macromolecules. 38(4): 1326-1334. 2005. 
 
131. Armstrong, J.K., Wenby, R.B., Meiselman, H.J., Fisher, T.C. The 
hydrodynamic radii of macromolecules and their effect on red blood cell 
aggregation. Biophysical Journal. 87(6): 4259-4270. 2004. 
 
132. Weirich, J., Seiler, L., Hug, M.J., Fleckenstein-Grün, G. Ca(2+) entry into 
primary cultured pig coronary smooth muscle cells after previous store 
depletion by repetitive P2Y purinoceptor stimulation. Cell Calcium. 29(5): 359-
367. 2001. 
 
133. Gockerman, A., Clemmons, D.R. Porcine aortic smooth muscle cells secrete a 
serine protease for insulin-like growth factor binding protein-2. Circ. Res. 76(4): 
514-521. 1995. 
 98
 
134. Hahn, M., McHale, M., Wang, E., Schmedlen, R., West, J. Physiologic 
pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue 
engineered vascular grafts. Annals of Biomedical Engineering. 35(2): 190-200. 
2007. 
 
135. Buxton, A.N., Zhu, J., Marchant, R., West, J.L., Yoo, J.U., Johnstone, B. 
Design and characterization of poly(Ethylene Glycol) photopolymerizable 
semi-interpenetrating networks for chondrogenesis of human mesenchymal 
stem cells. Tissue Engineering. 13(10): 2549-2560. 2007. 
 
136. Gregory, T.R. Nucleotypic effects without nuclei: genome size and erythrocyte 
size in mammals. Genome. 43(5): 895-901. 2000. 
 
137. Miller, E.J., Gay, S. Collagen: an overview. Methods Enzymol. 82: 3-32. 1982. 
 
138. Luo, Y., Kobler, J.B., Zeitels, S.M., Langer, R. Effects of growth factors on 
extracellular matrix production by vocal fold fibroblasts in 3-dimensional 
culture. Tissue Engineering. 12(12): 3365-3374. 2006. 
 
139. Grande-Allen, K.J., Calabro, A., Gupta, V., Wight, T.N., Hascall, V.C., Vesely, 
I. Glycosaminoglycans and proteoglycans in normal mitral valve leaflets and 
chordae: association with regions of tensile and compressive loading. 
Glycobiology. 14(7): 621-633. 2004. 
 
140. Calabro, A., Hascall, V.C., Midura, R.J. Adaptation of FACE methodology for 
microanalysis of total hyaluronan and chondroitin sulfate composition from 
cartilage. Glycobiology. 10(3): 283-293. 2000. 
 
141. Hahn, M., Jao, C., Faquin, W., Grande-Allen, K. Glycosaminoglycan 
composition of the vocal fold lamina propria in relation to function. Annals of 
Otology, Rhinology, and Laryngology. 117(5): 371-381. 2008. 
 
142. Zhang, G., Wang, X., Wang, Z., Zhang, J., Suggs, L. A PEGylated fibrin patch 
for mesenchymal stem cell delivery. Tissue Engineering. 12(1): 9-19. 2006. 
 
143. Salinas, C.N., Anseth, K.S. The influence of the RGD peptide motif and its 
contextual presentation in PEG gels on human mesenchymal stem cell viability. 
Journal of Tissue Engineering and Regenerative Medicine. 2(5): 296-304. 2008. 
 
144. Burdick, J.A., Anseth, K.S. Photoencapsulation of osteoblasts in injectable 
RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 
23(22): 4315-4323. 2002. 
 
 99
145. Salinas, C.N., Anseth, K.S. The enhancement of chondrogenic differentiation 
of human mesenchymal stem cells by enzymatically regulated RGD 
functionalities. Biomaterials. 29(15): 2370-2377. 2008. 
 
146. Benoit, D.S.W., Schwartz, M.P., Durney, A.R., Anseth, K.S. Small functional 
groups for controlled differentiation of hydrogel-encapsulated human 
mesenchymal stem cells. Nat. Mater. 7(10): 816-823. 2008. 
 
147. Bryant, S.J., Anseth, K.S. Hydrogel properties influence ECM production by 
chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J. Biomed. 
Mater. Res. 59(1): 63-72. 2002. 
 
148. Bryant, S.J., Anseth, K.S. Controlling the spatial distribution of ECM 
components in degradable PEG hydrogels for tissue engineering cartilage. J. 
Biomed. Mater. Res. Part A. 64(1): 70-79. 2003. 
 
149. Munoz-Pinto, D.J., McMahon, R.E., Kanzelberger, M.A., Jimenez-Vergara, 
A.C., Grunlan, M.A., Hahn, M.S. Inorganic-organic hybrid scaffolds for 
osteochondral regeneration. J. Biomed. Mater. Res. Part A. 94(1): 112-121. 
2010. 
 
150. Liao, H., Munoz-Pinto, D., Qu, X., Hou, Y., Grunlan, M., Hahn, M. Influence 
of hydrogel material properties on vocal fold fibroblast extracellular matrix 
production and phenotype. Acta Biomateralia. 4(5): 1161-1171. 2008. 
 
151. Bryant, S.J., Durand, K.L., Anseth, K.S. Manipulations in hydrogel chemistry 
control photoencapsulated chondrocyte behavior and their extracellular matrix 
production. J. Biomed. Mater. Res. Part A. 67A(4): 1430-1436. 2003. 
 
152. Peyton, S., Raub, C., Keschrumrus, V., Putnam, A. The use of poly(ethylene 
glycol) hydrogels to investigate the impact of ECM chemistry and mechanics 
on smooth muscle cells. Biomaterials 27(28): 4881-4893. 2006. 
 
153. Zhang, Z., Apse, K., Pang, J., Stanton, R.C. High glucose inhibits glucose-6-
phosphate dehydrogenase via cAMP in aortic endothelial cells. J. Biol. Chem. 
275: 40042-40047. 2000. 
 
154. Goodrich, R.P., Sowemimo-Coker, S.O., Zerez, C.R., Tanaka, K.R. 
Preservation of metabolic activity in lyophilized human erythrocytes. Proc. 
Natl. Acad. Sci. U. S. A. 89(3): 967-971. 1992. 
 
155. Keeley, F., Todorovich, L., Rabinovitch, M. Elastin and elastases in the 
pathology of the arterial wall. In: Robert, L., and Hornebeck, W., eds. Elastin 
and elastases. pp. 169-184. Boca Raton: CRC Press. 1989. 
 100
156. Andreeva, E.R., Pugach, I.M., Orekhov, A.N. Collagen-synthesizing cells in 
initial and advanced atherosclerotic lesions of human aorta. Atherosclerosis. 
130(1-2): 133-142. 1997. 
 
157. Kratky, R.G., Ivey, J., Roach, M.R. Local changes in collagen content in rabbit 
aortic atherosclerotic lesions with time. Atherosclerosis. 143(1): 7-14. 1999. 
 
158. Handa, S., Sadi, A.M., Cybulsky, M.I., Stewart, D.J., Husain, M. Region-
specific patterns of vascular remodelling occur early in atherosclerosis and 
without loss of smooth muscle cell markers. Atherosclerosis. 196(2): 617-623. 
2008. 
 
159. Adiguzel, E., Ahmad, P.J., Franco, C., Bendeck, M.P. Collagens in the 
progression and complications of atherosclerosis. Vascular Medicine. 14(1): 
73-89. 2009. 
 
160. Gutierrez, P., O'Brien, K.D., Ferguson, M., Nikkari, T., Alpers, C.E., Wight, 
T.N. Differences in the distribution of versican, decorin, and biglycan in 
atherosclerotic human coronary arteries. Cardiovascular Pathology. 6(5): 271-
278. 1997. 
 
161. Wight, T.N., Merrilees, M.J. Proteoglycans in atherosclerosis and restenosis: 
key roles for versican. Circ. Res. 94(9): 1158-1167. 2004. 
 
162. O'Brien, K.D., Olin, K.L., Alpers, C.E., Chiu, W., Ferguson, M., Hudkins, K., 
Wight, T.N., Chait, A. Comparison of apolipoprotein and proteoglycan deposits 
in human coronary atherosclerotic plaques : colocalization of biglycan with 
apolipoproteins. Circulation. 98(6): 519-527. 1998. 
 
163. Evanko, S., Raines, E., Ross, R., Gold, L., Wight, T. Proteoglycan distribution 
in lesions of atherosclerosis depends on lesion severity, structural 
characteristics, and the proximity of platelet-derived growth factor and 
transforming growth factor-beta. Am. J. Pathol. 152(2): 533-546. 1998. 
 
164. Rodriguez-Lee, M., Ostergren-Lunden, G., Wallin, B., Moses, J., Bondjers, G., 
Camejo, G. Fatty acids cause alterations of human arterial smooth muscle cell 
proteoglycans that increase the affinity for low-density lipoprotein. Arterioscler. 
Thromb. Vasc. Biol. 26(1): 130-135. 2006. 
 
165. McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., Chen, C.S. Cell 
shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. 
Developmental Cell 6(4): 483-495. 2004. 
 
 101
166. Hahn, M.S., Miller, J.S., West, J.L. Laser scanning lithography for surface 
micropatterning on hydrogels. Advanced Materials. 17(24). 2939-2942. 2005. 
 
167. Hahn, M.S., Taite, L.J., Moon, J.J., Rowland, M.C., Ruffino, K.A., West, J.L. 
Photolithographic patterning of polyethylene glycol hydrogels. Biomaterials. 
27(12): 2519-2524. 2006. 
 
 
 
 
 
 
 
 102
VITA 
 
Name:                    Xin Qu 
Address:                200 Jack E Brown Building 
  3122 TAMU 
  College Station, TX 77843-3122 
 
Email Address:       quxinwly@hotmail.com 
 
Education:              B.S., Life Sciences, University of Science and Technology of 
China, 2006 
 
Publications: X. Qu, A.C Jimenez-Vergara, D.J. Munoz-Pinto, D. Ortiz, R.E. 
McMahon, D Cristancho, S. Becerra-Bayona, V. Guiza-Arguello, 
K.J. Grande-Allen, M.S. Hahn. Regulation of smooth muscle cell 
phenotype by glycosaminoglycan identity. Acta Biomaterialia. 
7(3): 1031-1039. 2011. 
R.E. McMahon*, X. Qu*, A.C. Jimenez-Vergara, C.A. Bashur, 
S.A. Guelcher, A.S. Goldstein, M.S. Hahn. Electrospun mesh 
hydrogel composites for tissue engineered vascular grafts. Tissue 
Engineering Part C. 17(4): 451-461. 2011. 
H. Liao, D. Munoz-Pinto, X. Qu, Y. Hou, M. Grunlan, M.S. 
Hahn. Influence of hydrogel mechanical properties and mesh size 
on vocal fold fibroblast extracellular matrix production. 
Acta Biomaterialia. 4(5): 1161-1171. 2008. 
 
A. Bulick, D. Munoz-Pinto, X. Qu, M. Mani, D.Cristancho, 
M.Urban, M.S. Hahn. Impact of endothelial cells and mechanical 
conditioning on smooth muscle cell extracellular matrix 
production and differentiation. Tissue Engineering. 15(4):815-825. 
2009. 
 
*Authors contributed equally to this work 
                  
 
